Sequelae of external causes of morbidity and mortality

VWXY20_SEQUEL_EXTER_CAUSES_MORBIDI_MORTA

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Y85-Y89 Cause of death: ICD-10 — Y85-Y89 2 out of 7 registries used, show all original rules.	12098
4. Check minimum number of events None	12098
5. Include endpoints VWXY20_SEQUEL_TRANSPO_ACCIDENTS VWXY20_SEQUEL_OTHER_ACCIDENTS VWXY20_SEQUEL_INTENTI_SELF_H_ASSAU_EVENTS_UNDET_INTENT VWXY20_SEQUEL_W_SURGI_MEDICAL_CARE_EXTER_CAUSE VWXY20_SEQUEL_OTHER_EXTER_CAUSES	12098
6. Filter based on genotype QC (FinnGen only)	11704

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: V|W|X|Y

NAME	VWXY20_SEQUEL_EXTER_CAUSES_MORBIDI_MORTA
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	VWXY20_SEQUEL_TRANSPO_ACCIDENTS\|VWXY20_SEQUEL_OTHER_ACCIDENTS\|VWXY20_SEQUEL_INTENTI_SELF_H_ASSAU_EVENTS_UNDET_INTENT\|VWXY20_SEQUEL_W_SURGI_MEDICAL_CARE_EXTER_CAUSE\|VWXY20_SEQUEL_OTHER_EXTER_CAUSES
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Y8[5-9]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Y8[5-9]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sequelae of external causes of morbidity and mortality based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	11704	6466	5238
Unadjusted period prevalence (%)	2.34	2.29	2.40
Median age at first event (years)	64.01	61.58	67.01

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12098: Matched controls
120980

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.5

309.9

1170

3608

N02BE01

ATC

paracetamol; systemic, rectal

3.6

309.3

11232

94854

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

308.1

3263

17042

NGC00

NOMESCO Finland

Exchange of a loose part of prosthesis in knee joint

28.3

307.7

358

130

ZXD05

NOMESCO Finland

Urgent procedure

2.8

307.7

5007

24660

S73.0

ICD-10 Finland

Dislocation of hip

18.4

307.7

327

182

J01FF01

ATC

clindamycin; systemic

2.3

307.7

4022

21602

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

307.7

2433

9837

NGC30

NOMESCO Finland

Secondary implantation of prosthesis in knee joint, special prosthesis

27.3

307.7

415

157

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

33.6

307.7

1125

368

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

3.6

307.7

1484

4571

X59

ICD-10 Finland

Exposure to unspecified factor

3.3

307.7

3629

13815

N02AX02

ATC

tramadol; systemic, rectal

2.5

307.7

6476

38027

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

3.1

307.7

2035

7490

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

8514.5

307.7

2146

TQW11

NOMESCO Finland

Vacuum treatment of wound

6.4

307.7

579

936

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

307.7

3898

20725

N02AA05

ATC

oxycodone; systemic

2.6

307.7

2898

13244

NFC40

NOMESCO Finland

Repair of hip prosthesis by bone transplant to acetabulum

28.1

307.7

299

109

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.3

307.7

2421

4021

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.1

307.7

736

1272

ZXA00

NOMESCO Finland

Right side

2.2

307.7

3945

21534

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

307.7

1961

7722

ZXE20

NOMESCO Finland

More than three and less than five hours

2.9

307.7

2413

9493

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

10.8

307.7

368

349

9294

FHL

Endoprosthesis replacement of the entire hip joint (eg Charnley)

13.1

307.7

340

267

T84.8

ICD-10 Finland

Other complications of internal orthopaedic prosthetic devices, implants and grafts

35.3

307.7

249

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.9

307.7

885

1366

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.8

307.7

2123

8567

J04AB02

ATC

rifampicin; systemic

13.7

307.7

565

431

N03AX12

ATC

[U] gabapentin; oral

2.5

307.7

2624

11908

WX320

NOMESCO Finland

Spinalanesthesy

2.5

307.7

3879

19304

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

13.5

307.7

699

548

T81.9

ICD-10 Finland

Unspecified complication of procedure

8.1

307.7

592

766

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.5

307.7

2565

11807

NF1AA

NOMESCO Finland

Hip X-ray examination

3.5

307.7

1792

5752

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

16.3

307.7

328

206

S18

ICPC

Laceration/cut

2.4

307.7

6613

40923

ZXA05

NOMESCO Finland

Left side

2.3

307.7

3712

19864

N03AX16

ATC

[U] pregabalin

2.4

307.7

3652

18356

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

7308.6

307.7

1892

B01AB05

ATC

enoxaparin; parenteral

3.3

307.7

5799

26299

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

5.6

307.7

1248

2446

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

6.9

307.7

552

833

Y88.0

ICD-10 Finland

Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use

269.5

307.7

315

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4503599627370496.0

307.7

5707

NFC00

NOMESCO Finland

Exchange of a loose part of prosthesis in hip joint

31.9

307.7

365

118

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.1

307.7

6042

39272

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

31.9

307.7

1284

448

ZXE10

NOMESCO Finland

More than one and less than three hours

2.4

307.7

5395

30425

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

8.4

307.7

806

1015

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

7.4

307.7

2158

3463

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

7.7

307.7

502

677

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

10.9

307.7

4593

6418

Y86

ICD-10 Finland

Sequelae of other accidents

3087.9

307.7

608

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

307.7

4650

25854

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

25.8

307.7

2596

1268

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

4.1

307.7

1494

4036

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.3

307.7

1136

2830

WX402

NOMESCO Finland

General anaesthesia

2.6

307.7

3358

15744

NGC20

NOMESCO Finland

Secondary implantation of prosthesis in knee joint, normal prosthesis

33.3

307.7

365

113

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.6

307.7

1502

4530

X58

ICD-10 Finland

Exposure to other specified factors

2.7

307.7

2313

9598

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

15278.0

307.7

1368

NFH30

NOMESCO Finland

Reduction of dislocation prosthesis of hip joint, closed

23.8

307.7

356

154

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

7.4

307.7

840

1208

M16.1

ICD-10 Finland

Other primary coxarthrosis

3.3

307.7

2338

8159

S97

ICPC

Chronic ulcer skin

3.6

307.7

1198

3606

ZZH31

NOMESCO Finland

Bone allograft, small pieces

12.9

307.7

321

255

J01XX08

ATC

linezolid; systemic

15.0

307.6

273

186

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.3

307.5

3236

16854

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

305.7

2608

12415

WX002

NOMESCO Finland

Sedation and analgesia

2.3

293.8

2935

14922

NFU00

NOMESCO Finland

Removal of partial prosthesis from hip joint, other or unspecified

79.0

292.6

156

J01DB01

ATC

cefalexin; oral

2.6

282.2

10408

85464

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

279.8

2647

13122

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

277.3

5556

36450

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

277.2

6153

41795

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

16.3

276.9

235

147

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

273.6

2136

9723

NGU00

NOMESCO Finland

Removal of partial prosthesis from knee joint, other or unspecified

71.3

273.4

148

Y89

ICD-10 Finland

Sequelae of other external causes

905.3

271.8

266

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

4.2

269.9

756

1892

M79.6

ICD-10 Finland

Pain in limb

1.9

264.1

5488

36264

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.0

260.9

1257

4473

M96.6

ICD-10 Finland

Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate

13.9

257.6

238

174

C03CA01

ATC

furosemide; systemic

2.0

254.2

4188

25496

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.4

253.5

2184

10356

A46

ICD-10 Finland

Erysipelas

2.3

253.0

2230

10678

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.8

250.9

1361

5164

ZXE00

NOMESCO Finland

One hour or less

1.9

243.4

5075

33305

A02BC02

ATC

pantoprazole; systemic

2.0

241.7

8581

66794

J01MA12

ATC

levofloxacin; systemic

2.2

238.2

2668

14054

B01AB10

ATC

tinzaparin; parenteral

2.6

238.1

1575

6602

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.1

232.1

1072

3715

J01MA02

ATC

ciprofloxacin; systemic

1.9

230.9

5118

34085

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

229.0

1791

8109

ZZA00

NOMESCO Finland

Split skin graft

4.3

226.9

604

1452

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

226.7

5313

35948

NGC60

NOMESCO Finland

Exchange or addition of patellar part

14.8

226.2

202

139

L13

ICPC

Hip symptom/complaint

2.1

225.8

2583

13684

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

225.7

2770

15068

NGC99

NOMESCO Finland

Other secondary prosthetic replacement inknee joint, other or unspecified

25.1

222.5

156

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

220.6

8673

68648

A28

ICPC

Limited function/disability NOS

2.1

216.9

2458

12952

JN3AD

NOMESCO Finland

Abdominal CT examination

2.4

212.7

1716

7859

R4110

NOMESCO Finland

Physiotherapy

1.9

212.6

3671

22427

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.8

211.6

1141

4300

NFU20

NOMESCO Finland

Removal of internal fixation device from femur

8.6

211.3

272

323

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.7

210.6

505

1117

SPAT1153

SPAT

Removal of sutures

1.9

207.2

4177

26770

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

7.2

206.8

311

443

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

202.2

1519

6729

7151E

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, LONKKANIVEL]

9.1

200.9

246

274

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.0

197.7

580

1497

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

6.6

197.1

322

501

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

196.5

1656

7713

L28

ICPC

Limited function/disability (L)

2.0

196.5

2481

13554

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.6

195.5

1309

5492

WX306

NOMESCO Finland

Lumbar epidural anesthesy

3.0

195.3

946

3359

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.5

192.8

690

2041

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.7

191.9

643

1821

WX212

NOMESCO Finland

Femoral plexus blockade

4.5

191.7

483

1111

H02AB06

ATC

prednisolone; systemic

1.8

191.4

5971

43238

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

4.4

190.5

498

1179

B01AB04

ATC

dalteparin; parenteral

3.0

188.6

883

3074

B01AX06

ATC

[U] rivaroxaban

4.4

187.4

479

1114

NFH10

NOMESCO Finland

Reduction of dislocation of hip joint, closed

21.8

181.2

134

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

180.0

1426

6451

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

175.9

2236

12191

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.0

174.7

513

1324

R50.9

ICD-10 Finland

Fever, unspecified

2.1

173.5

2025

10699

NGW10

NOMESCO Finland

Reoperation for deep infection in in surgery of knee or lower leg

43.3

172.9

103

T88.9

ICD-10 Finland

Complication of surgical and medical care, unspecified

12.0

168.9

170

143

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.8

168.9

531

1438

NFJ62

NOMESCO Finland

Internal fixation of fracture of other parts of femur with plate

8.5

167.8

217

259

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

3.9

167.3

517

1383

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

164.9

4714

32890

Y89.1

ICD-10 Finland

Sequelae of war operations

+∞

163.9

157

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

163.8

3713

24275

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

3.2

162.6

665

2135

AA1AD

NOMESCO Finland

CT of head and brain

1.8

162.4

3509

22612

NF3AA

NOMESCO Finland

Femur X-ray examination

4.3

160.1

419

992

Y87.1

ICD-10 Finland

Sequelae of assault

794.0

159.9

157

W19

ICD-10 Finland

Unspecified fall

2.3

159.4

1390

6534

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

5.0

159.2

347

708

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

158.2

4466

30959

NFW10

NOMESCO Finland

Reoperation for deep infection in in surgery of hip or thigh

33.6

157.1

100

T84.4

ICD-10 Finland

Mechanical complication of other internal orthopaedic devices, implants and grafts

17.8

156.9

127

NFS10

NOMESCO Finland

Incision and debridement of infection of hip joint

34.4

156.6

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.8

155.9

288

506

NFJ64

NOMESCO Finland

Other internal fixation of fracture of other parts of femur

14.0

152.5

140

101

J01CF05

ATC

flucloxacillin; systemic

2.7

152.2

903

3556

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

152.2

4411

30711

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

151.2

4177

28702

Z3226

NOMESCO Finland

Physiotherapist

1.9

150.3

2347

13646

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.9

148.8

748

2701

Y85.0

ICD-10 Finland

Sequelae of motor-vehicle accident

1473.0

147.1

143

SPAT1255

SPAT

Intravenous administration of medicine

2.5

145.8

1021

4352

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

144.7

1689

8876

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.5

143.7

977

4106

N06AX21

ATC

duloxetine; oral

2.1

143.4

1532

7788

R06.0

ICD-10 Finland

Dyspnoea

1.7

143.3

3348

21915

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.6

142.8

879

3522

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

142.2

863

3434

A02BC01

ATC

omeprazole; systemic

1.7

141.9

3410

22482

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

141.6

3552

23690

P01AB01

ATC

metronidazole; oral, rectal

1.6

140.9

4712

33854

NFC99

NOMESCO Finland

Other secondary prosthetic replacement in hip joint, other or unspecified

17.7

140.4

114

N06AX11

ATC

mirtazapine; oral

1.7

139.6

4082

28327

WZC30

NOMESCO Finland

Teaching

1.9

138.8

2038

11581

UJF32

NOMESCO Finland

Coloscopy

1.7

137.8

3289

21613

B01AF01

ATC

rivaroxaban; oral

2.0

137.3

1711

9192

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

136.8

3128

20306

N02BF02

ATC

pregabalin; oral

2.6

136.6

846

3398

NG1DA

NOMESCO Finland

X-ray of knees

4.5

136.3

343

787

Y96.9

ICD-10 Finland

Unspecified type of accident

4.4

136.0

349

813

NGS10

NOMESCO Finland

Incision and debridement of infection of knee joint

14.7

135.6

121

A02BC05

ATC

esomeprazole; systemic

1.6

135.0

4888

35705

L15

ICPC

Knee symptom/complaint

1.7

133.7

2920

18696

WX702

NOMESCO Finland

Supraglottic ventilation device

2.6

133.0

811

3232

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.2

132.8

364

892

C07AB07

ATC

bisoprolol; oral

1.6

132.4

5855

44793

S72.0

ICD-10 Finland

Fracture of neck of femur

3.0

132.0

617

2138

T84.9

ICD-10 Finland

Unspecified complication of internal orthopaedic prosthetic device, implant and graft

16.9

131.4

109

NG1AD

NOMESCO Finland

Knee CT examination

4.8

131.0

298

630

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

5.5

130.8

257

478

L17

ICPC

Foot/toe symptom/complaint

1.7

130.0

3500

23680

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.3

129.1

335

787

M01AH05

ATC

etoricoxib; oral

1.6

129.1

7106

57082

WX400

NOMESCO Finland

Inhalation anesthesy

2.9

128.0

620

2191

M48.0

ICD-10 Finland

Spinal stenosis

2.0

127.8

1646

8930

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.1

127.7

1341

6757

N05CF01

ATC

zopiclone; oral

1.6

127.5

3918

27388

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

126.5

1717

9481

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

4.0

125.7

370

955

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

125.6

1197

5806

TQW40

NOMESCO Finland

Remowal of suture of skin

2.3

125.1

988

4433

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.3

124.9

991

4455

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

124.9

1340

6803

M25.5

ICD-10 Finland

Pain in joint

1.6

123.3

3722

25853

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

2.8

122.3

627

2284

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

5.8

121.1

222

387

NHG20

NOMESCO Finland

Fusion of talocrural joint

7.6

119.6

170

227

L89

ICPC

Osteoarthrosis of hip

3.0

119.6

565

1968

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

2.5

119.4

802

3344

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

6.2

118.5

202

328

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.9

118.5

589

2110

A06AD11

ATC

lactulose; oral

1.9

118.1

1880

10913

JAH00

NOMESCO Finland

Laparotomy

3.3

118.0

451

1386

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.3

117.9

919

4097

R60.0

ICD-10 Finland

Localized oedema

1.9

117.7

1609

8890

WX213

NOMESCO Finland

Lower leg blockade

6.3

117.3

197

315

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.8

117.3

183

271

Z3231

NOMESCO Finland

Registered nurse

1.6

116.9

3291

22407

NHQ40

NOMESCO Finland

Amputation of toe

4.3

116.5

303

713

JN4AD

NOMESCO Finland

Body CT examination

2.0

115.6

1338

6975

T90.5

ICD-10 Finland

Sequelae of intracranial injury

5.4

115.1

229

431

WX704

NOMESCO Finland

Intubation

2.2

115.0

1067

5114

WX892

NOMESCO Finland

Monitored bed care

2.2

114.8

1021

4810

M54.5

ICD-10 Finland

Low back pain

1.6

114.1

4135

29885

NFF20

NOMESCO Finland

Cleaning of hip joint, open

63.3

113.8

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

113.4

1686

9568

SPAT1263

SPAT

Sampling

1.6

113.1

4941

37232

NF1DA

NOMESCO Finland

X-ray of hips

3.6

113.0

375

1052

ZXA10

NOMESCO Finland

Bilateral

1.7

112.9

2311

14436

R52.2

ICD-10 Finland

Other chronic pain

2.9

112.4

544

1920

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

112.1

2727

17851

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

111.7

1085

5293

SPAT1229

SPAT

Assessment of need for aid

2.2

111.6

1067

5172

L90

ICPC

Osteoarthrosis of knee

2.3

111.4

902

4085

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

110.8

2800

18504

S72.3

ICD-10 Finland

Fracture of shaft of femur

5.7

110.4

208

372

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

108.8

1280

6704

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

108.0

953

4472

SPAT1301

SPAT

No procedures

1.6

107.1

3752

26811

M01AH01

ATC

celecoxib; oral

1.7

106.7

2159

13418

Z71.8

ICD-10 Finland

Other specified counselling

1.6

105.8

3518

24823

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

105.7

5936

46984

N05AH04

ATC

quetiapine; oral

1.8

105.5

2021

12363

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.1

105.2

452

1490

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.3

105.1

874

4000

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

104.9

7102

58425

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.3

104.8

806

3568

A01

ICPC

Pain general/multiple sites

2.0

103.6

1166

6004

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

103.1

1729

10163

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

102.7

3333

23349

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.8

100.9

315

847

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

100.3

2681

17902

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.3

99.6

826

3773

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

99.3

1883

11466

X57

ICD-10 Finland

Unspecified privation

3.4

99.3

368

1109

ZX120

NOMESCO Finland

Intravenous

2.0

98.0

1193

6313

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.0

97.8

149

215

M01AH02

ATC

rofecoxib; oral

1.8

97.5

1574

9135

TK800

NOMESCO Finland

Hemodialysis

3.5

97.2

337

973

QDA10

NOMESCO Finland

Incision of skin of lower limb

6.4

96.9

162

258

A41.9

ICD-10 Finland

Sepsis, unspecified

2.8

96.8

520

1939

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.5

96.2

340

994

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.8

96.1

487

1761

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

95.9

2070

13056

N06AA09

ATC

amitriptyline; systemic

2.0

95.9

1211

6487

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.4

95.4

693

2988

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

95.0

1433

8138

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.5

94.9

613

2504

B01AX05

ATC

fondaparinux; parenteral

5.6

94.6

182

332

N02BF01

ATC

gabapentin; oral

2.1

94.3

1024

5197

L70

ICPC

Infection of musculoskeletal system

7.9

94.2

129

165

NFC30

NOMESCO Finland

Repair of hip prosthesis by bone transplant to femur

18.4

94.1

WZA00

NOMESCO Finland

Concise certificate

2.2

94.1

806

3730

T84.62

ICD-10 Finland

Osteitis associated with dental implants

6.7

93.4

149

226

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

3.1

93.4

408

1358

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.0

93.3

439

1524

R03AC02

ATC

salbutamol; inhalant

1.5

92.8

6169

49995

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

92.7

710

3133

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

92.6

983

4946

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

92.4

1326

7408

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

3.3

92.3

366

1150

L01BA01

ATC

methotrexate; systemic

2.7

92.1

522

2000

SPAT1254

SPAT

Administration of medicine

1.7

91.9

1813

11144

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

91.6

1835

11325

M16.7

ICD-10 Finland

Other secondary coxarthrosis

5.8

91.2

167

291

B01AA03

ATC

warfarin; systemic

1.6

90.7

2283

14967

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.5

90.1

609

2540

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.9

89.8

441

1567

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

89.8

4303

32606

NGU20

NOMESCO Finland

Removal of internal fixation device from knee or lower leg

3.7

89.6

286

781

T81.7

ICD-10 Finland

Vascular complications following a procedure, not elsewhere classified

9.5

89.4

106

113

N06AX16

ATC

venlafaxine; oral

1.8

89.0

1582

9432

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.3

88.3

700

3134

T78.4

ICD-10 Finland

Allergy, unspecified

2.5

87.4

579

2392

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.3

87.4

705

3180

M09AX01

ATC

hyaluronic acid; parenteral

2.4

87.4

654

2856

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

87.3

7355

62081

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.8

87.2

1472

8638

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.3

87.2

670

2960

T93.2

ICD-10 Finland

Sequelae of other fractures of lower limb

4.9

86.8

190

389

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

86.6

640

2779

NFC50

NOMESCO Finland

Repair of hip prosthesis by bone transplant to femur and acetabulum

30.1

86.5

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.6

86.2

524

2078

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

86.1

955

4879

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

4.1

86.1

239

591

NFB60

NOMESCO Finland

Demanding prosthetic replacement of hip

7.4

85.3

124

170

M01AX05

ATC

glucosamine; oral

1.6

85.2

2303

15338

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

85.1

7976

68559

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.4

84.9

634

2765

NH1AD

NOMESCO Finland

Ankle and foot CT

3.3

84.8

333

1040

J01CA04

ATC

amoxicillin; systemic

1.6

84.7

9359

83184

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

84.5

2140

14021

Y88.2

ICD-10 Finland

Sequelae of adverse incidents associated with medical devices in diagnostic and therapeutic use

+∞

84.5

T88.8

ICD-10 Finland

Other specified complications of surgical and medical care, not elsewhere classified

7.0

84.4

128

184

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.1

84.1

813

3944

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

84.1

595

2534

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

84.0

4161

31627

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

83.8

1303

7452

T93.1

ICD-10 Finland

Sequelae of fracture of femur

11.2

83.8

C08CA01

ATC

amlodipine; oral

1.5

83.7

4399

33822

WX111

NOMESCO Finland

Local infiltration anesthesia

2.6

83.6

489

1903

NGQ20

NOMESCO Finland

Amputation of lower leg

7.1

83.5

126

180

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

83.4

4423

34058

S76

ICPC

Skin infection other

2.3

83.3

689

3139

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

83.2

1571

9516

N05BA04

ATC

oxazepam; oral

1.5

83.1

2944

20860

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

82.7

2475

16875

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

82.5

2835

19944

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

82.5

2156

14230

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7212

50246

2.08

319.74

11.1

6.6

1.20

1.21

mmol/l

33.42

6197

42512

(3013650) Neutrophils [#/volume] in Blood by Automated count

7970

57488

2.13

307.65

12.0

9.0

4.38

4.13

e9/l

14.77

7140

50049

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7776

46579

2.87

307.65

3.9

2.6

—

(3021788) Differential panel - Synovial fluid

819

1674

5.18

307.65

1.9

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2600

11439

2.62

307.65

10.2

6.9

5.15

5.07

kpa

4.22

2516

10900

(3044941) Cell count panel - Synovial fluid

719

1397

5.41

307.65

1.8

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

8331

58766

2.34

307.65

8.1

4.6

6.75

6.73

mmol/l

0.42

8051

54921

(3016502) Oxygen saturation in Arterial blood

2443

10214

2.74

307.65

10.5

7.3

96.03

95.59

3.03

2360

9823

(3022217) INR in Platelet poor plasma by Coagulation assay

7421

47098

2.49

307.65

19.0

15.5

1.27

inr

0.30

2542

13438

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1041

2868

3.88

307.65

2.5

1.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

6703

43491

2.21

307.65

7.4

4.8

34.10

35.41

g/l

57.04

6358

40250

(3003396) Base excess in Arterial blood by calculation

2618

11402

2.65

307.65

10.2

6.9

1.24

1.04

mmol/l

1.60

2196

9017

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

915

1157

8.47

307.65

7.1

6.4

11.79

11.67

mg/l

0.26

845

1062

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6752

45528

2.09

307.65

10.1

5.9

1.20

1.21

mmol/l

41.65

6379

41361

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4284

24159

2.20

307.65

3.7

2.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2599

11433

2.62

307.65

10.2

6.9

12.57

12.33

kpa

1.43

2518

10879

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2304

9374

2.80

307.65

10.9

7.7

115.70

121.36

g/l

31.08

2246

9118

(3044640) Blood type and Crossmatch panel - Blood

5510

31677

2.36

307.65

3.7

2.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1258

1690

8.19

307.65

2.3

1.4

—

(3023368) Bacteria identified in Blood by Culture

5628

27089

3.01

307.65

6.2

4.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7567

51990

2.22

307.65

8.2

6.1

10.81

11.50

umol/l

5.56

7276

49226

(3007853) Bacteria identified in Skin by Aerobe culture

3263

11539

3.50

307.65

2.5

1.7

—

(3042936) Bacteria identified in Isolate by Culture

4589

13598

4.83

307.65

3.4

1.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

6786

46670

2.03

306.37

8.9

6.4

—

(3006315) Basophils [#/volume] in Blood

7101

49804

2.03

301.31

8.2

5.8

0.04

e9/l

0.02

6271

42868

(3014111) Lactate [Moles/volume] in Serum or Plasma

2033

8671

2.62

301.27

9.8

6.7

1.30

1.36

mmol/l

1.88

2006

8433

(3001604) Monocytes [#/volume] in Blood

7085

49669

2.03

300.81

8.2

5.8

0.60

0.59

e9/l

2.11

6261

42779

(3000475) Leukocytes [#/volume] in Synovial fluid

880

2289

4.07

298.74

2.0

1.5

19259.67

13892.07

e6/l

1.66

585

1652

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2257

10200

2.49

295.68

4.6

3.4

—

(3013115) Eosinophils [#/volume] in Blood

7241

51418

2.02

293.22

8.5

6.0

0.20

0.19

e9/l

1.10

6514

44924

(3031040) Bacteria [#/volume] in Urine by Automated count

8712

66150

2.13

293.09

6.5

4.5

1927.41

1746.82

e6/l

0.09

193

909

(3019198) Lymphocytes [#/volume] in Blood

7183

51106

2.00

286.20

8.2

5.9

1.82

1.93

e9/l

3.91

6477

45014

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9669

76877

2.28

283.18

11.5

7.5

82.20

78.48

u/l

11.45

9355

72308

(3018418) pH of Serum or Plasma

4789

29780

2.01

279.80

6.1

4.0

7.40

0.50

1042

5675

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3068

16199

2.20

277.79

2.3

1.8

—

(3000991) Gas panel - Venous blood

1895

8296

2.52

263.29

12.3

8.0

—

(3002582) Erythrocytes [#/volume] in Urine

4822

30561

1.96

262.17

4.5

3.2

91.81

84.55

e6/l

0.10

3919

23475

(3000850) Epithelial cells [#/volume] in Urine

3692

21314

2.05

261.88

3.4

2.6

5.42

5.51

e6/l

0.17

3402

19068

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3034

16313

2.15

259.84

4.5

3.3

0.81

0.82

mmol/l

4.37

2894

15255

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2295

11020

2.34

259.31

2.1

1.7

—

(3026008) Bacteria identified in Urine by Culture

4878

31213

1.94

256.24

4.1

3.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2289

11034

2.33

255.99

2.2

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2563

12973

2.24

254.92

9.1

5.7

1.07

1.04

mmol/l

4.63

2451

12030

(3014007) Fractional oxyhemoglobin in Arterial blood

1550

6301

2.67

250.06

12.2

8.6

94.53

93.89

5.42

1541

6275

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1537

6263

2.67

246.60

12.2

8.6

0.67

0.68

0.37

1530

6218

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2879

15457

2.13

245.59

2.8

2.1

30.38

29.87

3.95

2797

14978

(3033658) Prothrombin time (PT) actual/Normal

4139

25340

1.96

245.21

6.2

3.9

88.61

89.37

1.12

4062

24707

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1535

6281

2.65

244.09

12.1

8.5

1.34

1.38

0.69

1527

6237

(3006504) Eosinophils/100 leukocytes in Blood

6538

46627

1.88

240.68

8.6

6.0

2.86

2.85

0.17

6248

43425

(3019069) Monocytes/100 leukocytes in Blood

6565

46904

1.87

240.05

9.0

6.3

8.65

8.63

0.23

6282

43761

(3018095) Leukocytes [#/volume] in Urine

5315

35553

1.88

238.92

5.2

3.7

100.33

98.67

e6/l

0.04

4134

25228

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4129

25436

1.95

238.79

2.7

2.2

3.09

2.96

mg/l

2.58

3673

21688

(3022096) Basophils/100 leukocytes in Blood

6370

45140

1.87

238.40

8.6

6.1

0.66

0.67

1.70

6086

41956

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1364

5352

2.75

235.21

12.6

9.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4808

31440

1.88

229.43

3.6

2.5

72.92

62.28

u/l

0.31

4515

28922

(3002030) Lymphocytes/100 leukocytes in Blood

6653

48138

1.85

229.36

8.7

6.1

25.83

27.67

34.87

6365

45016

(3030467) Casts [#/volume] in Urine by Automated count

4412

28095

1.90

228.44

4.3

3.2

0.45

0.43

e6/l

0.11

3558

21417

(3020779) Urea [Moles/volume] in Serum or Plasma

1902

8895

2.35

225.74

11.0

7.2

10.43

9.98

mmol/l

1.69

1841

8453

(3022948) Iron [Moles/volume] in Serum or Plasma

2882

15935

2.06

224.56

3.4

2.5

11.55

12.92

umol/l

19.97

2707

14789

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1653

7279

2.47

224.37

2.0

1.6

—

(36304419) Bacteria [Presence] in Urine

4297

27276

1.89

223.54

4.2

3.1

—

(3018010) Neutrophils/100 leukocytes in Blood

6548

47414

1.83

222.39

8.4

5.9

58.96

57.41

20.78

6264

44309

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2699

14753

2.07

215.84

3.4

2.5

2.26

2.33

g/l

5.76

2526

13593

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1468

6263

2.53

212.58

10.0

6.9

24.86

24.53

mmol/l

2.33

1408

5954

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

426

829

5.29

206.55

1.8

1.5

23.41

30.68

3.62

282

497

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2544

13848

2.06

204.41

3.5

2.5

21.09

22.39

4.23

2139

11763

(3037467) Urinalysis macro (dipstick) panel - Urine

8638

69002

1.88

204.21

6.1

4.4

—

(3044889) 12 lead EKG panel

8643

69259

1.87

199.67

4.9

3.8

—

(3019060) Gas panel - Arterial blood

1491

6628

2.43

196.69

6.7

4.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4722

31827

1.79

195.51

4.3

3.2

34.73

34.62

u/l

0.02

4518

30063

(3035350) Ketones [Presence] in Urine by Test strip

6588

48883

1.76

195.38

5.1

3.7

0.00

estimate

0.11

1580

9711

(3013707) Erythrocyte sedimentation rate by Westergren method

9036

73641

1.90

195.29

5.8

4.1

15.55

12.46

mm/h

54.08

8586

67959

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11203

99044

2.77

195.02

30.3

14.4

27.99

24.10

mg/l

31.44

10122

78825

(3009261) Glucose [Presence] in Urine by Test strip

6634

49397

1.76

193.60

5.1

3.7

0.01

0.00

estimate

0.42

1501

8913

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5861

42372

1.74

187.63

3.8

2.8

150.77

132.24

ug/l

3.39

5465

39036

(3021601) Nitrite [Presence] in Urine by Test strip

6550

48875

1.74

187.02

6.5

5.0

0.00

estimate

1.08

1512

9148

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1369

5983

2.45

186.99

9.7

6.9

24.95

24.77

mmol/l

1.11

1360

5932

(3026470) Cobalt [Mass/volume] in Blood

335

579

5.92

184.52

1.9

2.0

4.28

3.48

ug/l

0.98

312

525

(3025577) Chromium [Mass/volume] in Blood

331

566

5.98

184.34

2.0

2.72

2.38

ug/l

0.63

286

472

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

486

1162

4.32

183.47

1.8

1.5

64.86

58.36

2.75

318

725

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

934

3406

2.89

183.34

4.0

3.1

0.32

0.35

u/ml

1.68

532

1945

(3021589) Normoblasts [#/volume] in Blood

5978

43651

1.73

182.95

15.1

9.6

0.00

e9/l

0.52

4985

35651

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3197

19462

1.87

182.10

4.9

3.8

263.03

484.47

ng/l

2.92

2600

15259

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1855

9363

2.16

179.76

2.5

2.2

0.21

g/l

0.50

1744

8713

(3012544) pH of Venous blood

1878

9553

2.14

178.27

6.1

3.9

7.38

0.29

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4503

30609

1.75

176.13

2.6

2.1

221.39

215.75

u/l

0.11

4285

28633

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3445

21704

1.82

174.36

2.1

1.8

1.34

1.23

mg/l

1.41

2810

16552

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1022

4044

2.67

171.21

2.5

1.9

2.29

2.24

ug/l

0.05

938

3549

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1807

9221

2.13

169.45

6.1

3.9

5.87

5.83

kpa

0.78

1773

8947

(3002032) Base excess in Venous blood by calculation

1792

9196

2.11

165.27

6.4

3.9

1.78

1.92

mmol/l

0.82

1557

7785

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1205

5251

2.44

164.68

12.8

8.8

24.30

24.31

mmol/l

0.06

1189

5078

(40758558) Short blood count panel - Blood

3810

25149

1.75

162.15

8.8

6.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

749

2600

3.00

160.22

1.6

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

11272

101742

2.58

154.96

32.9

16.6

139.18

139.66

mmol/l

69.61

11149

99169

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5565

41029

1.66

154.71

2.7

2.2

76.47

77.63

nmol/l

2.39

5117

36712

(3023103) Potassium [Moles/volume] in Serum or Plasma

11284

102011

2.58

152.56

33.1

16.7

3.99

3.97

mmol/l

8.75

11150

99234

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4233

29275

1.69

149.01

3.5

3.0

1996.64

1430.93

ng/l

7.20

3775

25146

(3026782) Osmolality of Urine

3179

20385

1.76

147.03

3.7

2.9

515.90

542.76

mosm/kgh2o

10.37

2804

17464

(3015377) Calcium [Moles/volume] in Serum or Plasma

4722

33899

1.64

141.95

3.8

3.4

2.34

2.36

mmol/l

8.70

4300

29586

(3015736) pH of Urine

5333

39469

1.63

141.77

4.6

3.4

5.84

5.86

0.14

250

2702

(3027945) Reticulocytes/100 erythrocytes in Blood

2028

11469

1.92

140.33

3.2

2.5

1.85

1.77

3.07

1857

10079

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5190

38229

1.63

140.13

4.7

3.7

57.14

75.99

ng/l

0.44

3845

26560

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

861

3493

2.58

136.21

2.9

2.3

519.37

607.37

ug/l

0.29

827

3279

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

741

2790

2.76

136.01

3.1

2.6

3.59

3.60

g/l

0.10

717

2647

(3034891) Synovial lining cells/100 cells in Synovial fluid

246

425

5.89

135.46

1.7

1.5

4.64

3.25

0.64

(3029937) Albumin [Presence] in Urine by Test strip

3837

26398

1.66

134.57

5.7

4.1

0.00

estimate

2.99

1453

8810

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2745

17270

1.76

133.68

3.6

2.8

1.03

1.34

e6/l

1.08

1654

9918

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1520

7969

2.04

130.13

4.4

2.6

62.99

65.36

ml/min/173m2

1.39

685

3196

(3000494) Fungus identified in Specimen by Culture

1996

11485

1.88

130.05

1.9

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

3487

23621

1.67

128.65

1.7

1.5

20.69

20.27

nmol/l

0.56

3121

20136

(3002385) Erythrocyte distribution width [Ratio]

9742

84813

1.76

127.46

32.5

17.1

14.80

15.05

3.28

9637

83281

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1989

11609

1.85

123.28

4.5

4.2

240.46

243.33

u/l

0.41

1891

10911

(3024354) Oxygen [Partial pressure] in Venous blood

1439

7561

2.03

121.96

4.8

3.3

4.75

4.55

kpa

2.78

1410

7304

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1937

11348

1.84

118.15

3.7

2.7

7.84

8.46

umol/l

0.62

1677

9845

(3004119) Hemoglobin [Mass/volume] in Venous blood

1204

5997

2.12

117.67

4.7

3.5

122.44

128.96

g/l

17.98

1176

5850

(3018405) Lactate [Moles/volume] in Arterial blood

833

3561

2.44

117.43

5.9

4.0

1.37

1.39

mmol/l

0.15

816

3501

(3047181) Lactate [Moles/volume] in Blood

762

3128

2.53

117.21

8.2

5.9

1.31

mmol/l

0.03

680

2765

(3023520) Reticulocytes [#/volume] in Blood

1559

8612

1.93

113.84

3.0

2.5

71.50

69.36

e9/l

1.37

1160

6515

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4978

37581

1.55

112.98

5.4

3.9

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1000

4727

2.22

111.39

7.5

4.2

24.06

24.14

mmol/l

0.34

995

4631

(3026493) Urate [Moles/volume] in Serum or Plasma

3717

26335

1.59

110.91

3.3

2.6

3517.63

4686.35

umol/l

1.09

3267

22887

(3020564) Creatinine [Moles/volume] in Serum or Plasma

11331

104725

2.29

109.12

32.0

16.8

81.99

77.91

umol/l

13.29

11331

104690

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1592

8974

1.89

108.98

2.4

2.2

366.19

375.44

nmol/l

0.96

1502

8217

(3020891) Body temperature

880

4010

2.29

106.97

7.1

4.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5374

41585

1.53

106.92

2.2

2.0

93.73

95.67

pmol/l

2.43

2983

21634

(3020630) Protein [Mass/volume] in Serum or Plasma

1503

8396

1.90

105.57

2.7

2.5

65.61

66.34

g/l

3.00

1399

7581

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

969

4644

2.18

104.05

4.3

2.9

1.35

1.25

1.97

964

4616

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1155

5921

2.05

103.93

1.7

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3324

23251

1.59

103.20

4.8

3.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2470

16062

1.68

102.88

3.9

3.0

3.16

2.53

e6/l

1.74

1390

8767

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

947

4537

2.18

101.70

4.3

2.9

0.65

0.02

942

4515

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1517

8692

1.85

97.93

3.7

2.9

222.25

201.57

ng/l

1.20

1404

7891

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1590

9297

1.82

95.97

3.3

2.4

66.56

42.05

u/l

0.61

1353

7939

(3017143) Hepatitis C virus Ab [Presence] in Serum

1771

10695

1.77

95.85

1.9

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1128

5941

1.99

93.70

2.0

1.7

—

(40761511) CBC panel - Blood by Automated count

11093

102533

1.99

93.48

26.4

13.6

—

(3003694) ABO and Rh group [Type] in Blood

3693

26941

1.53

93.19

1.5

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

941

4653

2.11

92.90

1.9

1.7

1.62

1.55

g/l

1.43

811

3981

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

859

4108

2.17

92.41

7.5

5.1

1.80

1.62

4.64

802

3849

(3007930) Methemoglobin/Hemoglobin.total in Blood

849

4066

2.17

90.97

7.6

5.1

0.90

0.89

0.56

792

3817

(3043409) Potassium [Moles/volume] in Arterial blood

693

3051

2.35

90.95

6.3

4.2

3.90

3.89

mmol/l

0.34

688

3022

(46235355) HIV 1 and 2 tests - Meaningful Use set

2411

16042

1.63

90.21

2.1

1.8

—

(3002256) Pathology report gross observation

2024

13022

1.67

86.04

1.4

1.3

—

(3039000) Anion gap in Blood

543

2201

2.54

85.35

9.4

6.9

11.02

11.27

mmol/l

0.93

488

1976

(3018572) Chloride [Moles/volume] in Blood

543

2202

2.53

85.27

9.4

6.9

105.02

105.16

mmol/l

0.28

488

1977

(3005719) IgG [Mass/volume] in Serum or Plasma

1293

7350

1.85

84.89

3.1

2.7

10.26

10.51

g/l

1.08

1183

6726

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

660

2930

2.32

84.87

1.4

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1235

6947

1.87

83.77

2.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

654

2921

2.31

82.89

3.0

2.3

89.52

91.55

1.43

639

2803

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

616

2683

2.37

82.73

3.5

2.6

192.22

193.31

0.10

587

2546

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

555

2335

2.44

80.50

2.0

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1313

7616

1.81

80.48

5.6

3.8

115.81

89.97

ng/l

8.86

1183

6498

(3028626) Oxygen [Partial pressure] in Capillary blood

542

2265

2.46

79.77

4.3

3.2

8.11

8.15

kpa

0.18

534

2208

(3019150) Specific gravity of Urine by Refractometry

2988

21428

1.52

79.08

5.6

4.1

1.02

kg/l

0.77

435

3264

(3037522) Nuclear Ab [Titer] in Serum

2010

13161

1.63

79.04

1.4

1.3

551.42

524.17

titre

0.24

415

2756

(3024928) Oxygen saturation in Venous blood

500

2023

2.54

78.84

5.0

3.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2670

18697

1.55

78.81

3.0

3.1

2.46

2.45

mmol/l

1.35

2363

16305

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11227

105029

1.96

78.73

16.1

10.5

26.21

26.11

u/l

0.11

11007

101084

(3019309) Folate [Moles/volume] in Red Blood Cells

2752

19414

1.54

78.50

1.9

1.7

1277.15

1160.97

nmol/l

8.59

2237

14541

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8622

75885

1.47

76.49

4.5

4.0

14.86

14.82

pmol/l

0.71

7970

68721

(3017181) Myelocytes/100 leukocytes in Blood

1411

8501

1.75

75.69

4.7

4.1

0.84

0.95

0.99

562

2952

(3010144) Erythrocytes [#/volume] in Synovial fluid

291

900

3.29

75.28

1.6

1.3

144825.66

143895.07

e6/l

0.01

202

610

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1456

8871

1.73

75.00

2.6

2.3

6.91

7.25

ug/l

0.25

1311

7652

(3041096) Erythrocytes [Presence] in Urine by Automated

3503

26181

1.48

75.00

4.6

3.4

—

(1616796) Gas panel - Central venous blood

529

2263

2.40

73.89

4.4

3.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1038

5740

1.88

73.87

2.1

1.9

1.26

1.36

g/l

0.67

950

5213

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2985

21658

1.50

73.84

1.8

1.7

26501645.82

30383450.24

pmol/l

0.14

2498

17806

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2030

13540

1.60

73.42

1.9

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

908

4814

1.96

73.34

4.7

3.4

25.09

25.21

mmol/l

0.41

880

4668

(3015235) Bicarbonate [Moles/volume] in Capillary blood

571

2536

2.31

73.20

4.0

3.0

24.71

24.78

mmol/l

0.16

562

2484

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

622

2874

2.23

72.54

1.6

1.7

0.24

0.23

g/l

1.71

586

2714

(3036489) Thrombin time

724

3564

2.10

71.85

2.8

2.1

22.06

21.52

0.69

645

3105

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

9984

91001

1.56

70.93

5.4

4.8

2.10

2.13

mu/l

0.03

9317

83102

(3019230) Fractional oxyhemoglobin in Venous blood

421

1653

2.60

70.59

4.9

3.0

65.63

63.89

0.84

421

1647

(3002179) Metamyelocytes/100 leukocytes in Blood

1291

7738

1.75

70.22

4.4

3.9

0.65

0.69

0.23

484

2553

(40761536) Microorganisms panel - Urine sediment

1388

8506

1.71

69.68

5.5

4.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

519

2267

2.35

69.11

2.0

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2598

18529

1.51

69.08

1.6

1.5

2.52

2.44

g/l

0.99

1647

11094

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

626

2971

2.17

68.24

1.6

1.20

1.18

g/l

1.19

593

2808

(3021440) Promyelocytes/100 leukocytes in Blood

1322

8088

1.71

66.60

4.7

4.1

0.09

0.11

0.88

480

2549

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7453

64571

1.40

66.44

4.2

3.1

58.26

48.54

u/l

11.30

7030

59848

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

463

1960

2.42

66.14

8.8

5.4

1085.08

2002.95

iu/ml

0.42

277

(3009445) Proteinase 3 Ab [Units/volume] in Serum

815

4310

1.96

66.13

1.5

1.6

8.39

16.91

u/ml

1.38

125

(3021901) Oxygen saturation in Capillary blood

439

1819

2.47

65.72

3.4

2.8

—

(40761535) Cells panel - Urine sediment

1347

8332

1.69

65.07

4.6

3.5

—

(3027315) Oxygen [Partial pressure] in Blood

516

2312

2.29

64.72

5.0

4.0

8.50

8.61

kpa

0.73

506

2260

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7015

60316

1.39

64.39

3.3

2.9

—

(3009508) Creatinine [Moles/volume] in Urine

4030

31604

1.41

64.18

3.7

3.2

7.07

7.51

mmol/l

8.13

3463

26482

(3010421) pH of Blood

569

2665

2.19

64.07

4.9

4.0

7.42

0.11

531

2418

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

392

1560

2.56

63.92

2.0

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

392

1560

2.56

63.92

2.0

1.6

—

(3025159) Blasts/100 leukocytes in Blood

1252

7654

1.71

63.06

4.7

4.1

0.51

0.32

0.29

407

2136

(3012501) Base excess in Blood by calculation

509

2297

2.27

62.75

5.0

4.0

2.57

2.51

mmol/l

0.19

390

1548

(3013290) Carbon dioxide [Partial pressure] in Blood

509

2299

2.27

62.62

5.0

4.0

5.06

4.98

kpa

1.87

499

2248

(3007461) Platelets [#/volume] in Blood

11503

109449

2.04

62.57

41.6

21.2

256.49

249.73

e9/l

19.54

11347

106556

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1345

8401

1.68

62.48

5.4

3.8

1.22

1.23

mmol/l

1.71

1211

7301

(3009542) Hematocrit [Volume Fraction] of Blood

11497

109385

2.03

62.34

42.3

21.3

38.75

40.26

41.99

10676

102221

(3024731) MCV [Entitic volume]

11505

109513

2.03

61.91

41.4

21.2

91.30

91.08

5.87

11422

107889

(3035941) MCH [Entitic mass]

11504

109505

2.03

61.82

41.4

21.1

30.24

30.32

4.93

11420

107881

(3026361) Erythrocytes [#/volume] in Blood

11505

109523

2.03

61.73

41.5

21.2

4.32

4.48

e12/l

185.76

11314

106299

(3000963) Hemoglobin [Mass/volume] in Blood

11506

109543

2.03

61.61

41.8

21.3

129.40

135.11

g/l

271.46

11423

107933

(3023183) Ammonium ion [Moles/volume] in Plasma

464

2030

2.34

61.51

2.4

2.7

32.69

34.10

umol/l

0.67

420

1833

(3010813) Leukocytes [#/volume] in Blood

11503

109529

2.02

61.18

41.6

21.2

7.12

6.74

e9/l

39.75

11317

106277

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

126

7.19

60.79

10.1

11.5

5.31

5.24

mmol/l

0.08

126

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

671

3414

2.02

60.70

2.8

2.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

9883

90688

1.49

59.83

6.7

5.8

40.40

39.88

mmol/mol

5.87

9320

83563

(40767503) Oxygen content in Capillary blood by calculation

478

2150

2.27

59.37

3.0

2.5

15.71

16.21

1.64

257

1109

(40768804) Tissue Pathology biopsy report

4936

40545

1.37

57.60

2.4

2.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1066

6386

1.73

57.55

5.0

3.6

5.17

5.15

kpa

0.48

1025

6032

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

10074

92993

1.50

57.30

25.1

13.5

80.52

80.23

ml/min/173m2

0.57

8836

76925

(3025941) Bacteria identified in Stool by Culture

949

5529

1.78

56.43

1.3

—

(3009343) pH of Capillary blood

1050

6302

1.73

56.25

5.0

3.6

7.41

7.42

0.99

199

791

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

364

1488

2.49

56.09

3.9

2.7

695.36

1569.70

u/ml

0.69

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1020

6079

1.74

56.03

4.9

3.5

2.16

1.77

mmol/l

2.94

761

4500

(3006184) Hemoglobin [Mass/volume] in Capillary blood

490

2292

2.19

55.29

2.6

2.2

124.96

129.08

g/l

2.96

383

1646

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

797

4456

1.84

54.27

4.8

4.1

49.86

48.02

1.25

787

4403

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

285

1056

2.74

53.61

1.8

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

285

1056

2.74

53.61

1.8

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2290

16693

1.46

52.60

1.3

32.93

35.00

iu/ml

0.22

750

5286

(3019977) pH of Arterial blood

188

563

3.38

51.30

3.4

2.7

7.42

0.79

201

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2792

21197

1.41

51.11

1.3

1.60

1.76

u/ml

0.22

781

5589

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1110

6936

1.66

50.95

1.6

1.4

—

(3012516) Albumin [Mass/volume] in Urine

3730

29740

1.37

50.75

3.6

3.2

754.48

398.77

mg/l

3.07

2539

18824

(4035726) Immunohistochemistry procedure

1350

8925

1.58

49.09

1.5

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

386

1723

2.28

48.80

1.7

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1561

10695

1.53

48.30

4.2

4.1

19.03

25.83

ug/l

0.36

1242

8744

(40768797) Stomach Pathology biopsy report

1926

13802

1.47

47.81

1.3

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

626

3390

1.89

47.01

1.7

1.6

278.13

276.95

titre

0.00

149

(3003181) Sodium [Moles/volume] in Urine

387

1759

2.24

46.85

1.7

1.4

61.26

63.22

mmol/l

0.38

316

1400

(3052851) Hemolysis interference index of Serum or Plasma

580

3081

1.93

46.17

4.1

3.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

604

3253

1.90

46.12

3.2

39.18

47.92

mg/l

0.99

475

2638

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2141

15767

1.43

45.79

1.3

13.51

12.68

u/ml

0.20

811

6005

(3026250) Tacrolimus [Mass/volume] in Blood

147

405

3.66

45.60

43.4

34.1

7.49

7.29

ug/l

0.33

133

370

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

589

3159

1.91

45.54

3.1

3.2

1.74

3.13

ratio

1.12

237

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

373

1691

2.24

45.44

2.1

1.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

602

3255

1.89

45.41

3.2

55.98

75.40

mg/l

0.55

476

2635

(3022806) Fractional oxyhemoglobin in Capillary blood

309

1300

2.41

44.75

2.0

1.8

89.32

89.63

0.36

304

1282

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

441

2166

2.08

43.82

1.6

1.5

—

(3042733) HLA Ab [Presence] in Serum

120

296

4.08

43.52

6.2

4.8

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

123

309

4.01

43.51

1.3

1.2

0.33

0.30

g/l

2.56

247

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

314

1349

2.36

43.40

1.8

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3836

31284

1.33

43.24

4.1

3.8

15.28

9.13

mg/mmol

7.12

2528

19622

(40760888) Immunoglobulin light chains.free panel - Serum

480

2447

2.00

43.04

3.2

3.4

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

153

453

3.41

42.57

1.2

1.1

4.13

3.68

iu/ml

0.29

(3028271) Lactate [Moles/volume] in Capillary blood

355

1621

2.23

42.51

2.1

1.9

1.65

1.72

mmol/l

0.70

347

1587

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

349

1583

2.24

42.48

1.3

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

546

2929

1.90

42.16

1.4

260.38

272.04

ug/g

0.63

328

1723

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

683

3930

1.78

42.09

2.3

7.62

7.43

g/l

2.12

641

3524

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

682

3925

1.78

42.00

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

681

3921

1.78

41.87

2.3

3.79

3.68

g/l

1.00

639

3517

(3015171) Extractable nuclear Ab [Units/volume] in Serum

668

3825

1.79

41.85

1.2

1.3

1.21

0.91

u/ml

0.22

360

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

116

288

4.06

41.71

1.3

1.2

114.04

112.44

0.21

105

252

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

645

3667

1.80

41.38

2.3

10.06

10.21

g/l

0.37

598

3228

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

643

3676

1.79

40.48

2.3

3.09

2.95

g/l

2.51

602

3273

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

135

381

3.57

40.45

3.3

2.6

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

113

282

4.04

40.37

1.7

1.3

66.44

54.55

2.55

102

232

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

159

502

3.20

39.91

2.1

2.4

100.95

96.15

0.83

152

466

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

195

695

2.84

39.57

2.4

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10170

95496

1.41

39.56

5.0

4.6

6.05

5.95

mmol/l

8.43

9394

86759

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

229

887

2.61

39.55

1.9

1.5

—

(3011648) Oxygen content in Venous blood

204

751

2.75

38.95

3.1

2.5

10.85

10.98

0.16

204

751

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

328

1505

2.21

38.83

1.7

1.4

—

(3037756) Immunofixation for Serum or Plasma

422

2133

2.01

38.76

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1565

11183

1.46

38.72

2.1

1.7

1.60

1.46

7.21

1349

9740

(3048689) Calprotectin [Mass/mass] in Stool

1620

11704

1.44

37.73

2.3

135.92

137.50

ug/g

0.06

1304

9229

(3048929) Epstein Barr virus Ab [Presence] in Serum

510

2806

1.85

36.38

1.4

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

259

1108

2.37

36.19

1.8

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

140

5.24

36.09

5.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

383

1923

2.02

35.85

1.9

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

908

5874

1.59

35.76

1.4

1.3

325.82

223.26

u/ml

0.45

847

5405

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

332

1583

2.13

35.69

1.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

121

346

3.52

35.59

2.1

73.18

60.80

ug/l

0.72

116

337

(3036670) Protein [Mass/volume] in Synovial fluid

111

301

3.71

35.33

1.4

1.2

42.66

39.35

g/l

1.42

154

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3185

25908

1.31

34.86

1.8

1.6

1.44

1.37

mmol/l

2.79

2609

21688

(3023419) Bacteria identified in Sputum by Culture

317

1500

2.14

34.76

2.5

2.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

357

1787

2.03

33.71

1.4

1.3

256.90

274.85

u/ml

0.58

232

1135

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

374

1906

1.99

33.59

1.4

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

294

1371

2.17

33.47

1.7

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

342

1693

2.05

33.30

3.5

3.4

1.70

1.49

0.50

310

1494

(3030981) Hyaline casts [#/volume] in Urine by Automated count

824

5306

1.59

33.03

3.8

2.7

0.32

0.29

e6/l

0.20

807

5174

(3028707) Methadone [Presence] in Urine by Screen method

296

1397

2.15

32.70

3.4

2.9

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

146

494

2.98

32.63

1.4

1.5

7.43

8.64

ug/l

0.49

132

441

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

372

1917

1.97

32.37

1.8

1.4

21.75

16.41

u/ml

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

429

2319

1.88

32.35

1.7

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

282

1312

2.18

32.31

1.8

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

246

3.84

31.53

1.6

1.2

33.91

38.42

0.51

156

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

510

2935

1.77

31.35

2.4

2.3

0.01

0.04

g/l

2.37

477

2672

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

392

2079

1.92

31.34

1.6

1.4

55.60

29.61

e6/l

0.38

295

1593

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

392

2080

1.91

31.29

1.7

1.4

1287.00

2875.02

e6/l

0.40

313

1689

(3024263) Appearance of Synovial fluid

145

503

2.91

31.02

1.6

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

342

1738

2.00

30.98

1.9

1.4

116.58

114.36

u/ml

0.17

370

(3024471) HLA-A [Type]

105

301

3.51

30.83

1.0

—

(3022145) Colonoscopy Study observation

1514

11193

1.40

30.52

1.4

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

479

2738

1.78

30.13

2.5

2.3

0.00

g/l

0.50

446

2483

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

496

2865

1.76

30.10

1.6

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

486

2792

1.77

30.05

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

472

2693

1.78

29.88

2.5

2.3

0.00

g/l

-0.00

442

2475

(3000012) Reticulocyte production index

302

1488

2.06

29.81

2.2

2.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

489

2821

1.76

29.81

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

477

2739

1.77

29.55

1.6

1.4

26.52

15.87

iu/ml

0.45

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

239

1079

2.24

29.52

1.3

1.2

66.91

64.21

u/l

0.19

219

950

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

895

6022

1.53

29.44

3.2

3.4

4.41

4.45

pmol/l

0.46

799

5308

(3024980) IgG subclass 4 [Mass/volume] in Serum

313

1572

2.02

29.32

1.5

1.6

0.82

0.79

g/l

0.09

237

1179

(42529406) Shigella sp [Presence] in Stool by Culture

488

2830

1.75

29.21

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

408

2245

1.85

29.11

1.5

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

424

2362

1.82

29.07

1.5

1.3

601.92

524.00

mg/l

1.03

402

2238

(3020191) Ethanol [Moles/volume] in Serum or Plasma

186

760

2.47

28.85

1.7

1.4

1.54

1.29

promille

1.30

153

569

(3024932) HLA-DR beta [Type]

101

295

3.44

28.84

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

395

2160

1.86

28.75

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

395

2160

1.86

28.75

1.4

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

123

408

3.04

28.52

2.3

1.9

112.41

140.78

umol/l

0.62

217

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10388

98915

1.36

28.50

5.3

4.9

2.59

2.74

mmol/l

51.71

9652

90895

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

516

3062

1.72

28.46

2.4

2.2

36.63

37.68

g/l

3.23

473

2650

(3003338) MCHC [Mass/volume]

8912

83147

1.27

28.40

37.9

18.5

330.75

332.29

g/l

46.09

8868

82476

(3002619) Bacteria identified in Specimen by Culture

185

4.13

28.19

1.4

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

550

3339

1.68

27.87

2.7

2.4

0.79

0.92

g/l

0.33

489

2860

(40768446) Kidney Pathology biopsy report

113

362

3.14

27.82

2.3

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

364

1962

1.88

27.72

1.3

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

138

496

2.80

27.70

3.1

1.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

583

3612

1.65

27.31

3.5

3.4

253.47

2103.60

u/ml

1.61

500

3087

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

499

2975

1.71

27.06

1.6

0.22

5.20

iu/ml

1.23

114

663

(3044290) Cell count panel - Cerebral spinal fluid

355

1923

1.87

26.64

1.6

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

298

3.31

26.30

2.8

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

298

3.31

26.30

2.8

2.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

120

412

2.93

26.23

2.0

1.9

165.25

150.14

0.91

115

384

(3010375) cycloSPORINE [Mass/volume] in Blood

124

436

2.86

25.96

30.4

26.7

124.57

115.08

ug/l

0.56

364

(3017569) Oxygen content in Arterial blood

132

484

2.75

25.55

3.3

2.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

213

975

2.21

25.50

3.1

2.9

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

280

3.34

25.38

1.2

115.55

103.05

1.99

252

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

607

3868

1.60

25.35

1.1

2.16

13.20

u/ml

—

(40757494) Bilirubin.total [Moles/volume] in Blood

142

544

2.63

25.24

2.1

2.3

30.27

29.95

umol/l

0.01

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

160

650

2.48

25.19

1.4

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

191

840

2.29

25.18

2.1

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

191

840

2.29

25.18

2.1

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

191

840

2.29

25.18

2.1

1.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

272

3.36

25.12

1.2

92.38

85.94

0.74

136

(3009015) Lactate [Moles/volume] in Synovial fluid

110

4.93

25.01

1.4

1.2

7.39

6.12

mmol/l

0.60

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10175

96993

1.31

24.61

4.8

4.4

4.47

4.64

mmol/l

50.73

9509

89560

(3040151) Glucose [Moles/volume] in Capillary blood

239

1164

2.07

24.42

9.8

12.2

7.99

7.32

mmol/l

0.60

205

960

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

338

1859

1.84

24.20

4.6

3.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

275

1414

1.97

24.17

1.3

1.2

3.52

3.51

u/ml

0.00

467

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

733

4942

1.51

23.80

3.5

3.6

61.92

62.90

u/ml

0.02

714

4756

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

365

2067

1.79

23.74

1.4

1.3

3.73

3.79

mmol/l

0.55

342

1934

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

215

1021

2.13

23.49

2.0

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

147

595

2.49

23.36

1.4

1.2

—

(3042631) Mycobacterium sp identified in Specimen

269

1390

1.96

23.32

2.4

2.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

133

517

2.59

22.99

1.3

1.2

293.14

308.96

u/l

0.07

127

475

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

266

1376

1.95

22.99

1.3

1.2

3.39

4.13

u/ml

0.77

113

603

(3008295) Osmolality of Serum or Plasma

215

1030

2.11

22.97

1.6

1.4

277.84

279.35

mosm/kgh2o

0.40

170

784

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

9786

93003

1.27

22.95

4.2

4.0

1.36

1.29

mmol/l

15.81

9037

84671

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

183

3.79

22.82

1.4

1.2

90.15

75.65

1.17

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

171

749

2.30

22.80

1.9

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

211

1007

2.11

22.77

1.5

1.4

6.89

6.72

g/l

0.20

154

688

(3026389) Candida sp identified in Specimen by Organism specific culture

276

1451

1.92

22.75

1.6

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

414

2461

1.71

22.72

3.1

2.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

507

3180

1.62

22.61

1.6

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

431

2594

1.69

22.59

4.6

3.5

1.85

1.54

mg/l

7.73

399

2372

(3049717) Cytology report of Urine Cyto stain

592

3853

1.56

22.58

2.8

2.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

281

3.18

22.53

1.2

1.1

88.92

86.24

0.31

135

(3024139) IgG subclass 3 [Mass/volume] in Serum

210

1007

2.10

22.39

1.5

1.4

0.39

0.41

g/l

0.39

154

688

(3028192) IgG subclass 2 [Mass/volume] in Serum

210

1008

2.10

22.34

1.5

1.4

2.78

2.91

g/l

0.46

155

690

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

480

2983

1.63

22.22

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

437

2652

1.67

22.20

2.9

2.6

—

(4034850) Laboratory test

509

3216

1.61

22.03

14.5

10.0

—

(3052592) Norovirus Ag [Presence] in Stool

188

3.69

21.96

1.5

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10078

96272

1.28

21.70

4.6

4.4

1.41

1.46

mmol/l

27.92

9355

88383

(4062490) Immunoglobulin typing, IgG

208

1009

2.08

21.53

1.5

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

198

945

2.11

21.40

2.1

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

472

2952

1.62

21.31

2.6

2.2

5492.92

5307.99

u/l

0.04

163

1141

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

184

3.66

21.10

1.2

81.78

71.98

0.63

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

107

4.59

20.94

1.1

1.0

0.74

0.47

u/ml

0.16

(3022621) pH of Urine by Test strip

909

6588

1.41

20.21

3.6

3.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

235

1220

1.94

20.16

1.6

1.5

2067.73

2370.95

e6/l

0.29

161

886

(3036180) Methadone [Presence] in Urine

104

388

2.69

19.58

2.2

3.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

216

1101

1.98

19.55

1.5

88641.75

57753.92

e6/l

0.54

126

654

(3021387) Prolactin [Units/volume] in Serum or Plasma

462

2941

1.59

19.41

1.8

1.6

382.70

302.51

mu/l

2.96

426

2652

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

169

795

2.14

19.01

1.8

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

254

1380

1.86

18.99

1.5

1.4

31.26

32.48

g/l

0.75

226

1244

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

603

4097

1.50

18.85

1.9

38.34

39.06

u/l

0.37

544

3592

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

190

941

2.04

18.66

2.5

2.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

191

954

2.02

18.34

3.5

3.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

422

2668

1.60

18.26

1.2

124.12

142.90

titre

0.17

248

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

942

12522

0.73

18.26

4.8

4.5

32.60

32.57

0.03

702

8527

(3000492) Spirometry study

1220

9414

1.33

18.21

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1992

16388

1.26

18.10

1.7

1.5

—

(3011985) Renin [Units/volume] in Plasma

248

1359

1.84

18.07

1.4

52.38

59.36

mu/l

0.33

219

1205

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

202

1036

1.97

18.00

1.3

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

419

2654

1.60

17.99

1.2

993.57

871.38

titre

0.11

(3017354) Segmented neutrophils/100 leukocytes in Blood

202

1038

1.96

17.90

3.4

3.3

58.55

57.27

0.36

175

874

(3016879) Cocaine [Presence] in Urine

457

2958

1.57

17.89

3.0

2.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

571

3880

1.50

17.85

1.4

1.3

26.34

29.53

iu/l

1.56

476

3322

(3011288) Drugs identified in Urine by Screen method

349

2126

1.66

17.54

4.1

3.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

240

1316

1.84

17.47

1.2

1.1

120.28

116.54

0.89

227

1170

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

141

641

2.21

17.32

1.3

1.21

1.65

u/ml

0.32

349

(3009214) Lutropin [Units/volume] in Serum or Plasma

395

2490

1.61

17.32

1.4

10.92

10.31

u/l

0.37

313

2020

(3045788) Cell count panel - Pleural fluid

185

933

2.00

17.31

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

331

1998

1.68

17.24

3.3

3.1

0.85

0.82

nmol/l

0.58

259

1523

(3036782) Glucose [Moles/volume] in Pleural fluid

182

917

2.00

17.09

1.4

1.3

6.94

6.36

mmol/l

1.58

169

843

(3016038) Potassium [Moles/volume] in Urine

143

659

2.18

17.00

1.4

1.2

28.90

35.70

mmol/l

3.50

127

563

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

152

718

2.13

16.98

2.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

248

1387

1.80

16.94

5.2

4.8

357.74

360.20

umol/l

0.09

212

1182

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

310

2.75

16.79

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

232

1276

1.83

16.74

1.2

1.3

292.49

401.91

pmol/l

0.68

192

1084

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.23

16.71

5.0

4.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

206

1092

1.90

16.68

4.2

3.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

128

569

2.26

16.62

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

392

2.54

16.62

1.6

1.5

2464000.00

1408236.50

iu/ml

—

(3011412) CD3 cells [#/volume] in Blood

188

970

1.95

16.51

2.7

2.3

1.29

1.17

e9/l

0.85

166

868

(3013512) EKG study

3360

29427

1.20

16.29

4.6

4.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

246

1390

1.79

16.25

1.3

0.17

0.23

nmol/l

0.64

(3042111) Morphology [Interpretation] in Bone marrow Narrative

285

1683

1.71

16.13

1.8

1.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.28

16.13

1.2

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

134

616

2.19

16.06

1.2

27.56

23.33

u/l

0.43

116

515

(3010838) Calcium [Moles/time] in 24 hour Urine

291

1733

1.70

15.97

1.9

4.60

4.96

mmol/24h

1.05

253

1516

(3023420) DNA double strand Ab [Units/volume] in Serum

193

1017

1.91

15.94

1.5

1.4

29.38

28.30

iu/ml

—

(3012441) Differential panel - Pleural fluid

197

1046

1.90

15.90

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.36

15.86

1.1

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

244

1386

1.78

15.85

1.3

0.60

2.50

nmol/l

1.00

236

1336

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

187

979

1.92

15.75

1.2

1.1

94.79

95.94

0.21

177

912

(3045414) Leukocytes [Presence] in Urine

636

4523

1.43

15.71

2.2

1.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

327

2.64

15.69

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

221

1228

1.81

15.46

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

472

3181

1.50

15.39

3.0

2.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

221

1230

1.81

15.38

1.2

1.1

—

(40768443) Skin Pathology biopsy report

635

4532

1.42

15.38

1.3

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

224

1253

1.80

15.34

1.3

—

(1175426) CD3 cells/100 lymphocytes in Blood

156

775

2.03

15.29

2.3

2.0

72.96

72.74

0.05

145

742

(3028300) Cannabinoids [Presence] in Urine

474

3206

1.50

15.19

3.0

2.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

207

1134

1.84

15.17

1.2

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

135

637

2.13

15.17

1.3

1.2

85.19

88.93

u/l

0.18

118

547

(3016018) Differential panel - Cerebral spinal fluid

190

1013

1.89

15.17

1.6

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

561

3933

1.45

14.98

2.2

1.8

—

(3027008) Opiates [Presence] in Urine

472

3201

1.49

14.94

3.0

2.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

336

2.57

14.89

1.5

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

397

2.43

14.75

3.1

5.6

1918.13

1164.09

mg/l

0.15

285

(21494890) Protein electrophoresis panel - 24 hour Urine

193

1044

1.86

14.74

1.9

2.1

—

(36660697) Celiac disease serology panel - Serum

988

7618

1.32

14.74

1.2

—

(40762365) Oxygen content in Arterial blood by calculation

179

3.19

14.70

3.8

2.7

14.37

14.87

ml/dl

0.67

166

(3023511) Choriogonadotropin [Units/volume] in Urine

250

1462

1.72

14.70

1.6

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

398

2616

1.54

14.61

2.0

10.81

11.33

mg/l

0.61

368

2430

(3027944) Amphetamines [Presence] in Urine

463

3143

1.49

14.59

3.0

2.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

240

1393

1.74

14.50

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

151

759

2.00

14.35

2.3

2.0

14.59

15.39

0.39

145

740

(3020961) Endomysium IgA Ab [Titer] in Serum

612

4399

1.41

14.25

1.1

390.91

196.62

titre

0.38

114

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.03

14.21

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

194

1066

1.83

14.12

4.5

3.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

646

4698

1.40

14.06

1.3

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

373

2439

1.55

14.03

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

600

4310

1.41

14.02

2.5

1.9

—

(3045142) Bone marrow Pathology biopsy report

198

1098

1.82

13.99

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

266

2.72

13.95

2.5

1.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

206

2.97

13.93

14.3

7.6

—

(3051651) Icteric interference index of Serum or Plasma

126

600

2.11

13.87

5.2

3.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

202

1132

1.80

13.80

2.4

2.5

1.11

1.30

g/24h

0.53

115

556

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

268

2.70

13.76

1.2

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

112

511

2.20

13.74

2.5

1.9

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

377

2483

1.53

13.73

1.2

—

(3022313) Gas panel - Capillary blood

631

4589

1.40

13.73

5.7

3.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

112

512

2.20

13.68

2.5

1.9

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

213

1217

1.76

13.63

1.3

51.83

61.62

u/ml

0.22

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

236

2.81

13.61

14.1

7.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

376

2480

1.53

13.61

1.3

6.06

4.40

u/ml

0.24

250

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

302

1895

1.61

13.58

2.1

1.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

271

2.67

13.47

1.4

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

314

1993

1.59

13.47

1.3

1.2

49.76

42.13

u/ml

0.32

199

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

322

2058

1.58

13.41

1.2

1.70

4.45

u/ml

1.14

146

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

379

2513

1.52

13.39

1.3

6.13

6.76

u/ml

0.12

391

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

185

3.04

13.31

1.3

54.67

98.51

mg/l

0.27

138

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

219

2.84

13.09

1.3

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

719

5383

1.36

13.08

2.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

403

2721

1.50

13.07

1.3

22.22

39.84

u/ml

1.09

165

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

116

550

2.12

12.95

2.6

2.7

39.18

39.85

0.11

310

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

689

5147

1.36

12.72

2.1

1.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

171

937

1.84

12.61

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

105

484

2.18

12.60

1.7

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

187

2.95

12.46

3.1

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1063

8464

1.28

12.43

2.1

2.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

177

985

1.81

12.42

2.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

133

677

1.98

12.27

2.8

2.4

616.66

508.75

e6/l

1.46

105

565

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

102

470

2.18

12.27

3.5

3.4

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

102

471

2.18

12.21

1.6

1.3

57.69

64.15

0.31

(3017704) Immunofixation for Urine

114

550

2.08

12.19

1.5

1.6

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

322

2106

1.54

12.16

1.5

1.4

128.82

160.02

pmol/l

0.71

312

2046

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

594

7959

0.73

11.96

1.7

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

137

713

1.93

11.87

2.1

17.36

18.18

nmol/l

0.48

131

669

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

557

4069

1.39

11.83

2.0

1.8

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

134

694

1.94

11.78

3.0

2.5

698.59

664.88

e6/l

0.23

123

666

(3004451) EKG impression Narrative

104

493

2.12

11.67

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

255

1597

1.61

11.63

1.4

1.2

71.81

35.94

u/l

1.12

234

1380

(4200892) Spirometry reversibility

914

7204

1.29

11.57

1.5

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

106

510

2.09

11.45

1.2

1.1

32.89

26.90

u/l

0.42

100

449

(3012565) Volume of 24 hour Urine

105

504

2.09

11.41

2.2

1749.48

1922.09

0.97

440

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

166

931

1.79

11.40

1.4

1.3

428.94

360.99

u/l

0.30

155

881

(3020717) Zinc [Moles/volume] in Serum or Plasma

102

485

2.11

11.36

2.1

1.5

17.45

24.76

umol/l

2.13

464

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1153

9376

1.25

11.28

2.2

2.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

285

2.46

11.23

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

456

2.14

11.14

1.3

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

3.70

11.09

1.7

2.09

1.51

mg/l

1.04

(3016650) Hepatitis A virus Ab [Presence] in Serum

248

1566

1.60

10.96

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

105

513

2.06

10.91

1.2

1.1

93.69

85.98

u/l

0.31

100

452

(3024666) Lithium [Moles/volume] in Serum or Plasma

102

493

2.08

10.91

11.1

12.1

0.61

0.63

mmol/l

0.21

449

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

103

500

2.07

10.89

3.6

3.8

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

143

778

1.85

10.86

1.2

138.64

191.54

titre

0.39

149

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

308

2.38

10.85

1.6

1.2

32.26

24.53

0.38

(3035880) pH of Pleural fluid

111

556

2.01

10.78

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

111

560

1.99

10.57

1.9

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

155

876

1.78

10.41

1.6

1.3

1.49

1.48

nmol/l

0.06

142

781

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

111

565

1.97

10.32

1.9

1.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

360

2.23

10.27

1.2

0.06

0.34

g/l

—

(3037121) Protein [Mass/volume] in Urine

480

3507

1.38

10.23

3.6

3.1

0.42

0.32

g/l

1.09

247

1490

(44816559) Phosphatidylethanol [Mass/volume] in Blood

268

1753

1.54

10.19

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

216

1344

1.62

10.17

1.7

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

248

1595

1.57

10.16

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

414

2.13

10.13

2.2

2.3

50.40

53.04

umol/l

0.29

358

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

114

3.25

9.95

2.3

3.6

40.94

39.76

umol/l

0.12

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

122

650

1.89

9.93

1.7

1.5

7.08

6.63

u/l

0.13

100

515

(21494434) Karyotype in Bone marrow

150

852

1.77

9.93

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

877

7011

1.27

9.91

2.6

2.1

11.68

12.46

nmol/l

1.96

782

6216

(3042517) Benzodiazepines panel - Urine

3.71

9.84

3.3

2.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

119

632

1.89

9.79

1.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.37

9.78

3.6

3.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

129

704

1.84

9.75

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

130

712

1.83

9.72

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

129

705

1.84

9.71

1.2

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

153

2.88

9.66

1.0

0.23

2.79

u/ml

0.83

127

(3010503) CD19 cells [#/volume] in Blood

117

622

1.89

9.61

3.1

2.4

0.13

0.44

e9/l

1.44

111

599

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

120

644

1.87

9.57

1.9

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

791

6272

1.28

9.56

1.2

109.21

144.42

iu/ml

2.18

307

2316

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

214

1350

1.60

9.55

2.6

1067.23

1213.03

u/ml

0.04

208

1333

(40768806) Pleura Pathology biopsy report

177

1067

1.67

9.48

1.5

1.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

412

2.10

9.48

1.2

1.1

178.72

174.12

iu/ml

0.07

406

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

240

1558

1.55

9.47

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

129

711

1.82

9.46

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

129

711

1.82

9.46

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

128

704

1.83

9.45

1.2

1.1

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

3.95

9.29

2.3

1.5

0.45

0.72

0.42

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

120

651

1.85

9.27

3.1

2.5

0.22

0.23

e9/l

0.27

103

561

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

363

2.16

9.27

1.9

2.1

30.19

29.22

0.21

344

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

163

2.77

9.19

2.0

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3542

32263

1.14

9.14

5.0

2.41

3.27

ug/l

2.99

3167

28903

(21494755) Public health laboratory ask at order entry panel

652

8302

0.77

9.10

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

207

1315

1.58

9.00

1.7

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

207

1315

1.58

9.00

1.7

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

207

1316

1.58

8.97

1.7

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

163

977

1.68

8.95

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

347

2456

1.43

8.94

2.3

107.22

101.04

ug/min

0.11

213

1457

(3001729) Color of Synovial fluid

3.54

8.92

2.2

1.4

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

177

2.66

8.92

5.3

2.6

3213.83

2052.85

u/l

0.29

164

(3005988) Vibrio sp identified in Specimen by Organism specific culture

207

1319

1.58

8.89

1.7

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

256

2.35

8.78

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

123

687

1.80

8.68

1.6

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

387

2.07

8.63

2.3

3.0

—

(40768795) Lymph node Pathology biopsy report

164

995

1.66

8.61

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

125

704

1.78

8.58

1.6

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

102

541

1.89

8.49

2.0

1.8

1.93

2.90

u/field

0.91

377

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

517

1.90

8.30

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

367

2.08

8.26

1.1

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

100

532

1.89

8.26

1.4

1.11

1.23

nmol/l

0.65

410

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

128

736

1.75

8.21

1.6

1.3

2.22

2.09

mmol/l

0.50

121

691

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

484

1.93

8.21

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

118

664

1.78

8.15

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

352

2543

1.40

8.11

1.1

5.31

7.79

u/ml

0.52

299

(40768793) Breast Pathology biopsy report

308

2176

1.43

8.06

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

521

4005

1.31

8.02

6.1

3.8

24.76

24.86

mmol/l

0.30

486

3670

(3012494) Peanut IgE Ab [Units/volume] in Serum

236

2.34

7.99

1.1

1.24

6.41

u/ml

0.73

121

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.12

7.98

1.3

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

336

2418

1.40

7.93

1.2

—

(3023410) Appearance of Cerebral spinal fluid

152

928

1.65

7.84

1.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

127

739

1.73

7.83

1.3

1.6

28.76

23.18

u/ml

0.57

162

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

335

2.10

7.81

2.0

1.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

251

2.28

7.81

1.5

1.2

—

(3016228) CD19 cells/100 cells in Blood

423

1.97

7.81

2.5

2.0

5.83

8.70

2.10

409

(3006245) CD3-CD19+ cells/100 cells in Blood

370

2.03

7.73

2.2

12.21

10.06

0.40

345

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.64

7.72

1.8

1.6

3.88

1.61

mg/l

0.69

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

109

611

1.79

7.66

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

201

1323

1.53

7.55

1.7

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

109

614

1.78

7.54

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

238

1627

1.47

7.45

3.5

3.7

30.05

37.22

u/ml

0.66

231

1579

(3016750) Collection duration of Urine

102

567

1.81

7.38

2.0

2.2

496.07

497.08

min

0.03

425

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

3.19

7.37

1.3

1.2

133.35

108.84

ug/l

0.27

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

126

2.78

7.29

1.4

1.3

70.61

300.83

u/l

0.46

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

215

2.33

7.26

1.5

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

294

2103

1.41

7.22

3.2

3.4

55.25

613.24

u/ml

3.56

260

1920

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

116

677

1.72

7.12

1.4

13.39

12.65

umol/l

0.41

109

635

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

510

1.83

7.06

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

398

1.94

7.00

2.9

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

398

1.94

7.00

2.9

2.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

347

2568

1.36

6.96

1.3

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

358

2663

1.35

6.95

1.3

204.90

227.21

miu/ml

0.49

120

1202

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

112

653

1.72

6.92

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

291

2.10

6.91

1.1

1.2

—

(3008898) HLA-B27 [Presence]

406

3080

1.33

6.91

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

111

647

1.72

6.86

1.2

—

(3000330) Specific gravity of Urine by Test strip

641

5166

1.25

6.83

4.0

3.6

—

(3016244) Insulin [Units/volume] in Serum or Plasma

530

1.80

6.83

3.7

3.2

26.98

25.96

mu/l

0.10

498

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

402

1.92

6.81

2.9

2.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

409

1.91

6.81

2.6

2.0

—

(40757373) Influenza virus identified in Isolate

185

2.38

6.74

1.4

1.6

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.50

6.70

1.8

1.5

0.72

0.89

mg/l

0.22

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.50

6.70

1.8

1.5

1.13

1.34

mg/l

0.17

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.50

6.70

1.8

1.5

2.95

4.17

mg/l

0.39

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.50

6.70

1.8

1.5

0.41

1.46

mg/l

0.96

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.50

6.70

1.8

1.5

3.07

3.55

mg/l

0.12

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.50

6.70

1.8

1.5

2.40

4.27

mg/l

0.96

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.50

6.70

1.8

1.5

4.94

1.75

mg/l

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

345

2570

1.35

6.65

1.9

1.7

42.89

41.74

nmol/l

0.38

333

2480

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

550

1.77

6.62

1.1

1.2

1.11

1.06

ratio

1.45

185

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

408

5290

0.76

6.60

1.5

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

132

815

1.63

6.59

2.2

2.0

1.99

2.01

u/field

0.02

326

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

164

2.44

6.49

6.1

7.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

123

2.69

6.48

1.9

2.0

—

(3044927) Protein electrophoresis panel - Urine

159

1033

1.55

6.41

1.1

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

191

1291

1.49

6.40

1.5

1.3

29.51

27.68

u/l

0.31

171

1063

(3002079) Sodium [Moles/time] in 24 hour Urine

440

1.85

6.38

1.2

135.50

161.48

mmol/24h

2.91

440

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

120

731

1.65

6.33

1.4

1.3

12.00

13.22

u/l

0.37

106

670

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.58

6.30

1.4

1.1

1.08

1.05

u/field

0.08

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

239

1694

1.42

6.25

1.5

1.7

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

143

2.52

6.25

1.3

0.56

1.68

mmol/l

1.33

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

200

1373

1.46

6.21

1.1

51.22

12.07

au/ml

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

375

1.90

6.11

1.4

61.14

65.15

0.41

311

(3017732) Neutrophils [#/volume] in Blood

823

6893

1.21

6.10

3.7

2.9

4.59

4.94

e9/l

0.64

660

5465

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

341

1.94

6.07

2.5

2.8

29.85

27.88

umol/l

0.59

255

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

164

2.38

6.01

2.2

2.0

15.06

16.79

umol/l

0.43

164

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

128

805

1.60

5.97

2.2

1.8

3.88

4.14

mg/l

0.30

123

765

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

152

995

1.53

5.96

1.1

—

15.11

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

142

2.47

5.84

1.8

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

312

2340

1.34

5.81

1.8

3.26

8.20

iu/l

0.73

101

837

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

137

2.49

5.75

1.0

1.1

0.67

6.56

u/ml

1.09

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

114

2.64

5.71

1.5

1.4

70.35

74.18

0.24

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

192

1331

1.45

5.70

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

173

1177

1.48

5.66

3.2

3.3

6.03

11.43

nmol/l

0.57

163

1152

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

480

1.76

5.65

1.4

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

480

1.76

5.65

1.4

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

416

1.81

5.58

1.1

1693.92

1509.81

miu/ml

0.82

416

(3036071) Salmonella sp Ab [Titer] in Serum

296

1.96

5.56

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

453

1.77

5.56

1.7

1.6

3.32

4.99

nmol/l

0.63

371

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

251

1837

1.37

5.49

2.2

1.9

187.29

198.82

pmol/l

0.97

240

1720

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

119

752

1.59

5.48

1.4

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.14

5.45

1.3

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

106

652

1.63

5.45

1.9

1.5

92.28

83.10

umol/l

0.99

106

652

(43055514) Macroprolactin [Presence] in Serum or Plasma

198

2.18

5.41

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

186

1296

1.44

5.40

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

185

1288

1.44

5.40

1.1

1.54

1.52

g/l

0.29

177

1148

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

154

2.34

5.38

2.2

2.9

137.06

37.64

mg/l

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

450

3592

1.26

5.29

1.6

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.71

5.25

4.5

3.5

1.47

1.07

mg/l

0.43

(3000060) B lymphocytes [#/volume] in Blood

261

2.00

5.24

2.1

2.2

2037.24

228.63

e6/l

0.70

139

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

499

1.71

5.23

1.0

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

590

1.65

5.23

1.8

1.5

5.34

6.27

u/l

1.16

496

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

115

732

1.58

5.16

1.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

312

1.90

5.13

1.4

1.83

2.84

0.62

266

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

109

2.57

5.11

2.1

2.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.66

5.06

2.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

125

815

1.54

5.06

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

158

1082

1.47

5.05

1.8

1280.00

1582.61

titre

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

149

1013

1.48

4.95

2.1

12.84

7.15

umol/l

0.69

107

740

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

185

1311

1.42

4.94

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

268

1.94

4.89

1.1

1.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.48

4.88

1.1

1.0

0.03

0.09

u/ml

—

(3014271) Vancomycin [Susceptibility]

533

1.66

4.85

3.2

3.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

276

1.92

4.84

1.9

8.67

9.54

mg/l

0.66

225

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

549

1.64

4.83

1.6

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

306

1.87

4.76

2.4

3.2

7.60

mg/l

0.00

243

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

577

1.62

4.68

1.1

3.80

9.13

nmol/l

0.92

115

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

776

6635

1.18

4.63

2.4

23.99

23.62

au/ml

0.02

502

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

255

1926

1.33

4.62

3.8

1.8

0.91

0.81

nmol/l

1.35

212

1618

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.34

4.59

2.9

2.5

—

(3014891) Appearance of Pleural fluid

134

2.32

4.57

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

147

1014

1.46

4.57

1.1

—

(3004775) Volume in Urine collected for unspecified duration

120

795

1.51

4.56

2.1

2.3

770.16

642.78

1.95

538

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

153

1065

1.44

4.54

1.6

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

283

1.88

4.52

2.0

2.6

179.56

152.24

au/ml

0.14

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

214

2.01

4.49

1.7

2.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

711

6060

1.18

4.42

1.3

52.70

54.43

au/ml

0.05

326

(3019832) Treponema pallidum Ab [Presence] in Serum

895

7776

1.16

4.39

1.8

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

359

1.76

4.37

1.9

1.8

298.63

49074.69

u/ml

—

(3020393) Adenovirus Ag [Presence] in Stool

106

2.46

4.36

1.4

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

113

2.39

4.29

1.3

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

198

2.02

4.26

1.3

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

120

808

1.49

4.25

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

114

1679

0.68

4.22

1.7

1.6

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

192

2.03

4.21

1.3

1.2

1.32

1.66

mmol/l

1.33

117

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

248

1.90

4.18

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

248

1.90

4.18

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

248

1.90

4.18

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

248

1.90

4.18

1.2

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

4.80

4.17

10.8

8.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

635

1.55

4.16

1.3

57.00

66.43

titre

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

174

1261

1.39

4.15

1.4

0.32

0.39

nmol/l

0.80

132

965

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1414

12723

1.13

4.15

12.4

7.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

134

2.24

4.14

1.4

5.28

289388.39

nmol/l

0.91

113

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

167

2.10

4.11

1.1

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

271

1.85

4.11

1.6

1.5

10.30

8.92

ug/l

1.16

271

(3008116) Ketones [Moles/volume] in Urine by Test strip

201

1.99

4.10

1.6

1.3

—

(40762814) Titanium [Mass/volume] in Blood

181

2.05

4.08

2.1

2.2

6.92

3.26

ug/l

1.12

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

466

1.63

4.06

2.6

2.4

—

(3028433) Virus identified in Specimen by Culture

338

1.75

4.05

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

126

866

1.46

4.04

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

147

1042

1.42

4.00

1.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

119

811

1.47

3.99

1.3

8.61

8.64

mmol/l

0.02

114

781

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

130

2.23

3.98

1.9

1.6

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.60

3.96

1.0

0.01

4.66

u/ml

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

246

1.87

3.95

1.5

1.4

29.00

22.82

0.64

207

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

4.45

3.93

1.6

1.4

190.33

153.88

ug/l

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

144

2.16

3.91

2.0

1.2

39.15

53.80

1.15

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.63

3.89

1.0

0.72

0.84

u/ml

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

427

1.64

3.84

1.3

3.87

4.56

umol/l

0.77

394

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.68

3.81

1.2

0.74

1.15

ml/s/173m2

1.30

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

337

1.72

3.81

2.3

2.5

140.18

145.86

nmol/l

0.17

294

(3008037) Lactate [Moles/volume] in Venous blood

281

2213

1.28

3.81

3.8

3.3

1.65

1.63

mmol/l

0.15

273

2159

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.53

3.79

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

201

1.94

3.75

1.1

0.65

0.67

umol/24h

0.07

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

660

1.50

3.73

1.3

882.50

307.00

titre

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

230

1.87

3.71

1.7

1.5

0.33

0.39

ug/l

0.68

139

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

155

2.07

3.65

1.3

1.2

149.46

610.33

ng/l

0.43

105

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

137

977

1.41

3.64

1.3

—

(3034426) Prothrombin time (PT)

327

1.72

3.63

1.3

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.42

3.62

1.2

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.72

3.58

45.0

8.3

—

(3001186) Copper [Moles/volume] in Serum or Plasma

226

1.86

3.57

1.9

1.3

17.62

16.70

umol/l

0.47

202

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.39

3.55

2.1

1.7

59.18

42.78

umol/l

0.88

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2749

25771

1.09

3.53

4.5

4.3

22.47

21.96

0.83

1311

12844

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

216

1664

1.30

3.50

1.1

1.45

2.04

u/ml

0.54

130

836

(3025018) Bordetella pertussis Ab [Titer] in Serum

517

1.55

3.50

1.3

1.2

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

10.00

3.49

5.0

5.5

0.67

12.33

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.47

3.45

1.0

0.02

0.33

u/ml

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

512

1.55

3.42

1.7

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

512

1.55

3.42

1.7

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.34

3.40

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

102

701

1.46

3.35

1.1

340.23

267.94

mg/l

0.42

610

(3009871) Measles virus Ab [Titer] in Serum

313

1.70

3.33

1.5

1.7

—

(3016031) Almond IgE Ab [Units/volume] in Serum

2.71

3.31

1.0

0.47

0.89

u/ml

—

(3047189) Immunofixation for 24 hour Urine

485

1.55

3.29

1.9

1.7

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

493

1.55

3.29

2.6

2.4

202.58

204.01

u/l

0.08

488

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

510

1.53

3.26

1.1

1.09

1.08

u/l

0.05

236

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

234

1.80

3.23

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

584

1.49

3.22

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

165

1241

1.33

3.20

1.1

2.79

3.70

u/ml

0.42

563

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

213

1.83

3.20

1.2

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

667

1.46

3.19

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.53

3.19

1.6

1.4

628.12

455.51

nmol/l

0.45

(40765096) Chromosome analysis panel by Banding

288

1.70

3.15

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

117

2.14

3.15

1.0

—

(44813793) Dust mix specific IgE antibody measurement

653

1.46

3.14

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

104

728

1.43

3.13

1.2

58.27

40.89

mg/l

0.35

609

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

165

1.94

3.13

1.3

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

389

1.60

3.11

1.2

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

252

1.75

3.11

1.3

1.6

14.46

13.08

g/l

0.42

201

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

2.80

3.08

1.0

0.70

2.49

u/ml

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

337

1.63

3.04

1.3

1.4

75.35

212.01

nmol/24h

1.59

337

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

139

2.02

3.04

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.43

3.04

1.1

1.3

37.68

45.82

mg/l

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

146

1.99

3.03

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

254

1.73

3.03

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

307

1.66

3.02

4.4

2.9

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

203

1.83

3.01

2.0

1.6

240.70

123.42

ng/l

1.53

203

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

354

1.61

3.00

1.4

1.5

14.23

15.95

pmol/l

1.58

287

(44786800) Granulocytes/100 leukocytes in Body fluid

127

2.05

2.96

1.2

1.3

20.74

25.67

0.29

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

379

1.59

2.95

1.0

1.1

191.14

347.86

ng/l

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.71

2.91

3.8

4.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

557

1.48

2.91

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

574

1.47

2.89

1.1

6.57

10.38

iu/ml

1.03

133

(36303858) Crystals [Presence] in Urine

5.39

2.86

1.4

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

260

1.69

2.81

1.6

1.3

109.58

132.15

nmol/l

0.46

187

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

458

1.51

2.75

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.24

2.72

2.5

2.8

—

(3023383) Lactate [Moles/volume] in Pleural fluid

317

1.61

2.71

1.4

1.3

3.26

3.44

mmol/l

0.12

287

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

125

2.00

2.69

1.2

—

(3006462) Nitrate [Presence] in Urine

495

1.48

2.64

3.6

3.5

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.79

2.64

1.9

4.1

13.80

10.52

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.14

2.64

2.5

2.9

—

(3007463) Buprenorphine [Presence] in Urine

3.14

2.64

6.9

5.6

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

176

1.82

2.62

1.1

1.34

4.85

pmol/l

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

236

1.70

2.60

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

558

4887

1.15

2.58

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

252

1.67

2.57

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

385

1.54

2.57

1.5

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

466

1.48

2.56

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

114

2.02

2.55

1.1

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.73

2.54

1.2

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

5.46

2.54

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

246

1.67

2.51

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

108

2.04

2.51

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

412

1.51

2.49

1.0

1.1

103.64

94.60

1.40

317

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.46

2.48

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

255

1.65

2.47

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

100

730

1.37

2.45

3.6

2.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

386

4496

0.85

2.44

1.7

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

2.24

2.43

1.0

1.59

0.77

u/ml

0.21

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.13

2.43

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

110

2.00

2.40

2.1

2.0

1.22

1.18

mmol/l

0.04

(4281824) Cell count and differential, peritoneal fluid

143

1105

1.30

2.39

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

368

1.52

2.38

1.9

2.2

1443.78

4149.91

e6/l

0.53

255

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.50

2.35

1.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

125

1.92

2.34

1.6

1.5

0.22

0.27

nmol/l

0.26

(3013293) Extractable nuclear Ab [Presence] in Serum

154

1.82

2.33

1.4

1.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

187

1501

1.25

2.31

1.1

4.28

5.36

u/ml

0.49

117

771

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.37

2.29

1.0

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

324

1.55

2.28

1.6

2.0

15518.21

15530.89

e6/l

0.00

179

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

105

783

1.34

2.27

1.2

72.00

67.62

u/ml

—

(3016330) Potassium [Moles/time] in 24 hour Urine

134

1.87

2.26

1.1

1.3

—

87.63

—

(3030313) Adrenal Ab [Titer] in Serum

2.27

2.24

1.1

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.11

2.22

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.33

2.21

1.0

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

105

787

1.34

2.21

1.2

58.00

36.20

u/ml

0.36

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

158

1.77

2.16

2.1

3.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.69

2.15

2.4

1.4

—

(40768441) Liver Pathology biopsy report

722

1.35

2.14

1.6

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

2.45

2.10

1.3

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.20

2.09

4.1

5.2

—

(1002224) Polysomnography panel

424

3707

1.15

2.08

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

5.00

2.07

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.90

2.07

3.1

1.9

4.01

4.45

mmol/l

—

(3038026) Centromere Ab [Units/volume] in Serum

106

805

1.32

2.06

1.2

31.44

51.31

u/ml

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

117

1.88

2.05

11.4

7.5

—

(3035933) Granulocytes/100 leukocytes in Blood

261

1.57

2.05

2.7

1.5

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

4.00

2.04

1.2

1.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

747

1.33

2.02

1.2

1.75

5.56

u/ml

—

(3007733) Chloride [Moles/volume] in Urine

3.08

2.01

1.0

1.2

99.00

86.19

mmol/l

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

180

1466

1.23

2.00

1.1

34.79

7125.20

iu/ml

0.59

352

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.63

2.00

1.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

434

1.43

1.99

1.1

1.0

0.19

1.25

u/ml

0.87

111

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

115

889

1.30

1.98

1.4

1.2

—

(3045424) Erythrocytes [Presence] in Urine

204

1686

1.21

1.97

1.6

1.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

225

1.60

1.95

2.4

2.3

8.07

7.71

mmol/l

0.17

138

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.57

1.94

2.1

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

487

1.40

1.93

1.1

1.52

1.90

u/ml

0.11

153

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

454

1.41

1.92

1.1

2.83

19.07

u/ml

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

106

1.89

1.90

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

219

1.60

1.90

1.1

—

393.33

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.00

1.89

2.4

—

(3004616) Nuclear Ab [Presence] in Serum

152

1224

1.24

1.89

1.3

—

(40760410) HLA-B [Type] by High resolution

2.65

1.86

1.0

—

(46236302) HLA-C [Type] by High resolution typing

2.65

1.86

1.0

—

(40760409) HLA-A [Type] by High resolution

2.65

1.86

1.0

—

(3048879) Bone marrow aspiration report

292

1.51

1.86

2.8

1.8

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.98

1.84

2.6

2.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.20

1.84

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

502

1.38

1.81

2.1

91.12

158.76

ug/min

0.63

127

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

352

1.45

1.79

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

256

2186

1.17

1.76

5.8

3.5

25.66

28.02

mg/l

0.58

201

1361

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

139

1.73

1.75

1.1

—

(3018291) Platelet Ab [Presence] in Serum

3.33

1.74

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.33

1.74

1.2

1.4

2.08

2.24

mmol/24h

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.33

1.74

3.3

2.8

1.80

2.02

mu/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

741

1.30

1.72

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

340

1.44

1.69

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

138

1116

1.24

1.69

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.95

1.69

1.1

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

165

1361

1.22

1.68

1.1

1.60

1.48

u/ml

0.07

109

675

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

164

1.65

1.67

1.7

1.3

—

(40758292) HTLV I+II Ab panel - Serum

149

1.68

1.66

1.3

1.4

—

(4212803) Bone marrow aspirate examination

1.86

1.65

1.2

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.10

1.65

1.5

374.15

313.87

umol/24h

0.37

(3032057) Clostridioides difficile [Presence] in Stool

228

1.54

1.64

2.9

1.8

—

(3050794) Legionella sp Ab [Presence] in Serum

1.93

1.64

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

127

1.73

1.63

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

245

2105

1.17

1.59

4.1

3.3

7.54

7.65

mmol/l

0.27

236

2059

(3002331) Protein [Mass/volume] in Peritoneal fluid

230

1.52

1.59

1.4

26.19

25.88

g/l

0.04

177

(3042951) Complement C1q Ab [Units/volume] in Serum

2.33

1.58

2.3

1.1

30.40

10.83

u/ml

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

716

6572

1.10

1.58

1.2

—

(3044007) Cell count panel - Peritoneal fluid

296

1.45

1.57

1.9

2.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

130

1.69

1.52

1.1

1.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.33

1.52

4.0

3.5

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.59

1.51

1.3

—

mmol/l

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.59

1.51

2.1

4.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.83

1.51

1.0

0.64

0.14

u/ml

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

193

1.56

1.50

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

172

1443

1.19

1.50

1.0

1.1

0.48

1.12

u/ml

2.71

619

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.95

1.48

1.1

1.7

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.95

1.48

4.0

4.1

—

(3028717) Thiamine [Mass/volume] in Blood

116

1.73

1.48

1.5

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

116

1.73

1.48

1.1

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

429

0.65

1.48

1.3

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

115

929

1.24

1.47

3.3

3.0

102.95

50.63

mg/l

0.51

685

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.81

1.47

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

479

1.34

1.46

1.3

1.1

—

(3017400) Magnesium [Moles/volume] in Urine

2.73

1.43

1.0

3.06

2.18

mmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1542

14633

1.06

1.42

1.5

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

430

1.35

1.42

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

111

900

1.24

1.39

5.3

4.8

57.31

79.58

u/ml

0.41

268

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

768

0.75

1.36

1.2

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

2.94

1.36

1.6

1.4

—

0.80

u/field

—

(3034614) HLA Ag [Interpretation]

2.94

1.36

1.0

1.4

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

1.83

1.35

1.0

0.04

0.68

u/ml

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

151

1.59

1.34

1.5

1.4

15.21

9.92

0.36

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.78

1.32

1.1

1.2

2.01

1.60

umol/24h

0.99

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

192

1.51

1.31

2.8

3.0

136.11

143.69

ng/l

0.06

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

113

1.68

1.31

3.1

2.5

0.47

0.52

u/field

0.12

113

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

149

1766

0.84

1.31

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

317

1.39

1.30

1.0

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

149

1764

0.84

1.30

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

351

3145

1.12

1.29

1.9

—

(40763590) HLA-DQ beta [Type]

2.35

1.29

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

497

0.70

1.28

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

150

1771

0.85

1.27

1.4

—

(3013862) HLA-DP [Type]

2.29

1.26

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

150

1770

0.85

1.26

1.4

—

(3020650) Glucose [Presence] in Urine

252

1.43

1.25

1.3

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

616

1.27

1.25

6.9

6.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

244

1.44

1.25

1.1

1.2

347.39

296.88

pmol/l

0.15

176

(1761868) Lipid panel - Serum or Plasma

3265

33618

0.96

1.21

3.1

2.9

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

124

1.61

1.20

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

124

1475

0.84

1.17

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

165

1914

0.86

1.15

1.4

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

450

0.71

1.14

1.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

477

1.28

1.09

5.0

5.4

125.08

8202.46

u/ml

0.54

(37021550) Renin [Units/volume] in Plasma --upright

227

1.41

1.07

1.3

131.19

103.63

mu/l

0.18

167

(3014599) Egg white IgE Ab [Units/volume] in Serum

488

1.27

1.06

1.1

1.0

1.03

1.97

u/ml

0.59

120

(3005033) Fetal Nuchal fold Thickness US

121

1424

0.85

1.04

1.5

1.4

—

(3017509) Phencyclidine [Presence] in Urine

1.67

1.03

1.9

1.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

577

0.76

1.03

1.2

1.3

1.51

1.56

g/l

0.54

577

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

196

1.43

1.01

9.4

5.1

40.00

66.84

u/l

1.46

190

(4094501) Cardiovascular stress test using bicycle ergometer

289

2610

1.11

0.99

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

206

1.41

0.98

1.9

1.7

1.57

2.16

ug/l

1.10

104

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.63

0.97

1.0

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

132

1.52

0.96

1.3

1.4

—

250.19

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

722

1.21

0.95

1.0

301.23

287.98

mg/l

0.85

645

(3033705) Calcium.ionized [Moles/volume] in Venous blood

146

1267

1.15

0.95

2.9

2.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.77

0.94

1.2

1.1

—

(4146454) Self-monitoring of blood glucose

1106

0.84

0.93

2.8

2.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1129

10772

1.05

0.92

1.7

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

123

1428

0.86

0.92

1.5

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.71

0.92

1.1

—

(3006270) Folate [Moles/volume] in Blood

104

881

1.18

0.92

1.2

369.73

356.09

nmol/l

0.25

730

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

881

8350

1.06

0.92

1.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.63

0.90

1.7

2.3

—

(3025130) Human papilloma virus identified in Specimen

134

1163

1.15

0.89

1.8

1.7

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

111

1.53

0.87

1.1

1.2

—

(3033799) Differential panel - Peritoneal fluid

325

1.29

0.86

2.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

153

1.44

0.85

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.67

0.85

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

751

1.19

0.84

2.2

1.9

7.60

6.68

mmol/l

1.63

538

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.94

0.84

1.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.94

0.84

1.0

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

144

1639

0.88

0.84

1.4

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

415

1.25

0.84

1.9

1.7

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.78

0.84

1.0

8.33

mmol/l

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.56

0.84

2.8

2.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.76

0.83

1.1

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.76

0.83

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

391

1.25

0.80

3.1

2.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

225

1.33

0.77

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

309

3353

0.92

0.76

1.5

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.77

0.76

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.57

0.74

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

218

1.33

0.74

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.84

0.73

1.1

1.2

209.43

265.50

nmol/l

—

(3051593) INR in Capillary blood by Coagulation assay

488

1.21

0.72

12.3

12.0

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

1.52

0.72

2.4

1.9

60.11

61.73

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

117

1.45

0.71

2.6

2.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

134

1.42

0.71

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

229

1.31

0.70

1.3

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

283

1.27

0.69

1.4

1.2

47.09

428.46

ug/l

1.88

155

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

295

0.75

0.66

1.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

153

1.37

0.66

1.5

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

153

1.37

0.66

1.5

1.2

—

(3019174) dRVVT (LA screen)

1.51

0.66

1.1

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

111

1.44

0.65

1.1

1.0

—

(3015183) Erythrocyte sedimentation rate

440

1.21

0.64

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.60

0.61

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

235

1.28

0.61

1.4

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

113

1.42

0.61

1.1

1.0

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

12.30

—

(3051101) Glucose [Moles/volume] in Cord blood

174

0.69

0.58

3.2

6.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.58

0.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

140

1.36

0.58

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

105

935

1.12

0.55

1.3

1.4

3.95

4.20

ug/l

0.07

816

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

230

1.26

0.55

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

349

0.80

0.52

1.0

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

196

1.28

0.52

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

153

1.31

0.50

1.5

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.46

0.46

1.0

—

(3008607) Semen analysis panel

1.46

0.46

1.1

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.46

0.46

1.3

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.38

0.45

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.61

0.43

1.0

1.7

—

(3013762) Body weight Measured

1.56

0.42

1.0

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

105

1.33

0.41

1.3

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

261

1.19

0.38

1.4

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

543

1.12

0.37

1.3

5.88

5.82

mmol/l

0.09

516

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

143

1.26

0.36

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.27

0.36

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.27

0.36

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

123

1323

0.93

0.33

1.4

1.3

7.48

7.39

mmol/l

0.12

113

1159

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.28

0.32

1.3

1.1

—

(3003129) Base excess in Capillary blood by calculation

276

1.16

0.31

1.6

1.7

-0.45

0.63

mmol/l

0.90

255

(3022689) Creatine [Moles/volume] in Urine

284

0.84

0.31

1.4

1.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.35

0.31

2.1

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

186

0.81

0.30

2.3

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

186

0.81

0.30

4.7

6.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

144

1357

1.06

0.28

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

144

1357

1.06

0.28

1.1

—

(3011048) Pyruvate [Moles/volume] in Blood

1.27

0.27

1.4

1.2

96.00

86.63

umol/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

114

1075

1.06

0.23

1.1

2.95

3.55

u/ml

0.28

430

(40758358) Immune stain study

1.28

0.23

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

122

1155

1.06

0.22

1.1

3.61

3.68

u/ml

0.02

539

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

1.22

0.21

1.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.19

0.21

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.21

0.0

1.3

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

120

1264

0.95

0.21

1.4

1.5

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

1.14

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1344.62

—

(3001556) Androgen free Index in Serum or Plasma

1.25

0.20

1.4

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

673

1.07

0.20

1.3

170.87

181.03

pmol/l

0.21

673

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.20

0.19

1.8

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

261

2695

0.97

0.19

5.3

4.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1834

18535

0.99

0.19

3.0

0.71

0.78

ug/l

2.09

1291

12573

(3041806) Other cells [#/volume] in Blood by Manual count

270

1.11

0.18

1.8

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

374

0.91

0.18

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

128

1.17

0.18

1.7

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

269

2767

0.97

0.17

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.14

0.16

1.0

1.1

9.00

13.74

u/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

163

1574

1.04

0.16

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.10

0.15

1.9

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

104

1.15

0.12

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

310

3039

1.02

0.12

1.6

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

133

1.13

0.12

1.5

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

134

1301

1.03

0.11

2.3

2.1

22.80

25.21

mg/l

0.25

333

(3045683) HLA typing for celiac disease panel - Blood or Tissue

537

0.95

0.11

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

165

1.09

0.08

1.0

1.1

74.96

56.94

u/ml

0.38

157

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.83

0.08

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

208

2043

1.02

0.08

1.3

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.77

0.08

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.09

0.08

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.08

0.08

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

225

2214

1.02

0.07

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

955

0.97

0.07

1.0

0.04

0.39

u/ml

2.02

272

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.03

0.07

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

237

1.05

0.05

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.11

0.05

1.9

2.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

433

0.97

0.04

1.0

1.1

13.70

5.55

u/ml

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

101

1.09

0.04

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

111

1.08

0.04

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

146

1477

0.99

0.03

1.8

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

240

1.04

0.03

1.0

14.50

11.34

u/ml

0.14

141

(3019225) pH of Specimen

1034

10309

1.00

0.03

6.4

4.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

199

0.95

0.03

2.5

2.9

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

660

0.98

0.02

1.0

32.97

44.30

ng/l

2.57

443

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

657

0.99

0.01

1.0

819.65

726.90

ng/l

0.70

438

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

334

0.99

0.00

2.1

1.8

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

654

0.99

0.00

1.0

259.11

331.95

ng/l

2.47

448

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

334

3343

1.00

0.00

1.7

5.86

3.86

mg/l

1.25

269

2436

(3000285) Sodium [Moles/volume] in Blood

139

1.01

0.00

1.1

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.3

—

34.57

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.00

0.00

10.2

8.8

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.0

—

288.71

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.49

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

15.60

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.91

-0.00

1.0

1.1

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.85

-0.00

1.0

1.2

—

1.95

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.2

—

71.52

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

-0.00

0.0

1.2

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.96

-0.00

1.1

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_SEQUEL_EXTER_CAUSES_MORBIDI_MORTA – Sequelae of external causes of morbidity and mortality

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Sequelae of external causes of morbidity and mortality

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Sequelae of external causes of morbidity and mortality (VWXY20_SEQUEL_EXTER_CAUSES_MORBIDI_MORTA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints